[
  {
    "patient_admin": {
      "mrn": "MRN542417",
      "name": {
        "given": "Mia",
        "family": "Johnson"
      },
      "dob": "1967-04-08",
      "sex_at_birth": "Male",
      "gender_identity": "Male",
      "race": "White",
      "preferred_language": "Japanese",
      "address": "4053 Hickory Rd, Vernon, CT",
      "contact": {
        "phone": "555-0179",
        "email": "mia.johnson@example.com"
      },
      "identifiers": {
        "payer_member_id": "5089393113",
        "group_id": "48964"
      }
    },
    "coverage": {
      "payer": "Aetna",
      "plan_type": "Medicare Advantage HMO",
      "member_id": "5089393113",
      "group_id": "48964",
      "effective_start": "2023-08-27",
      "effective_end": null
    },
    "ordering_provider": {
      "name": "Dr. Jordan Rivera",
      "npi": "1028492780"
    },
    "rendering_facility": {
      "org_name": "Midtown University Hospital",
      "tin": "11-2233445",
      "npi": "1223344556",
      "location": "10 University Ave, New York, NY",
      "phone": "212-555-0198"
    },
    "lab_performing": {
      "lab_name": "GenomeDx Clinical",
      "clia": "06D2223334",
      "npi": "1992211110"
    },
    "diagnosis_and_stage": {
      "primary_icd10": "C34.90",
      "description": "Metastatic non\u2013small cell lung cancer, adenocarcinoma",
      "ajcc_edition": "8",
      "tnm": "T2aN1M1a",
      "stage_group": "IV",
      "ecog": 1,
      "date_of_diagnosis": "2022-08-16"
    },
    "pathology_synoptic": {
      "specimen": {
        "type": "Excisional biopsy",
        "site": "Lung, unspecified",
        "collection_date": "2024-10-27",
        "fixation": "Alcohol-based",
        "tumor_purity_pct": 30
      },
      "histology": "Adenocarcinoma",
      "grade": "G3",
      "tumor_size_mm": 60,
      "margins": "Positive",
      "lvi": "Present",
      "nodes_examined": 6,
      "nodes_positive": 4
    },
    "genomic_testing": {
      "current_test": {
        "test_id": "574a8b9d-7517-4ece-a5ab-b440ce212e33",
        "test_name": "Comprehensive Solid Tumor Panel (500 genes)",
        "cpt": "81455",
        "loinc_report": "81247-9",
        "methodology": "WES + RNA",
        "genes_analyzed": 334,
        "lab": {
          "lab_name": "GenomeDx Clinical",
          "clia": "06D2223334",
          "npi": "1992211110"
        },
        "specimen_link": {
          "type": "Excisional biopsy",
          "site": "Lung, unspecified",
          "collection_date": "2024-10-27",
          "fixation": "Alcohol-based",
          "tumor_purity_pct": 30
        },
        "report_date": "2024-06-08",
        "results": {
          "variants": [
            {
              "gene": "EGFR",
              "hgvs": "c.2573T>G (p.L858R)",
              "tier": "I"
            },
            {
              "gene": "TP53",
              "hgvs": "c.743G>A (p.R248Q)",
              "tier": "II"
            }
          ],
          "summary_metrics": {
            "PD-L1_cps": 55,
            "MSI": "Stable",
            "TMB": 10
          }
        },
        "classification_system": "AMP/ASCO/CAP tiers"
      },
      "prior_tests": [
        {
          "test_name": "Hotspot panel 50",
          "date": "2024-02-21",
          "key_findings": [
            {
              "gene": "TP53",
              "hgvs": "p.R273C",
              "tier": "II"
            }
          ],
          "lab": {
            "lab_name": "Legacy Molecular",
            "clia": "12D0001111",
            "npi": "1555999999"
          }
        }
      ]
    },
    "treatment_history": {
      "systemic_therapies": [
        {
          "rxnorm": "1597876",
          "drug": "Pembrolizumab",
          "start": "2024-03-22",
          "stop": null,
          "line_of_therapy": 1
        }
      ]
    },
    "imaging": [
      {
        "modality": "CT Chest/Abd/Pelvis",
        "date": "2024-12-10",
        "findings": "Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe",
        "accession": "ACC207175"
      }
    ],
    "labs": [
      {
        "loinc": "718-7",
        "name": "Hemoglobin [g/dL]",
        "value": 10.9,
        "unit": "g/dL",
        "date": "2024-04-09"
      },
      {
        "loinc": "777-3",
        "name": "Platelets [#/volume]",
        "value": 303,
        "unit": "10^3/uL",
        "date": "2024-12-18"
      },
      {
        "loinc": "2160-0",
        "name": "Creatinine [Mass/volume]",
        "value": 1.2,
        "unit": "mg/dL",
        "date": "2024-02-14"
      },
      {
        "loinc": "1751-7",
        "name": "Albumin [Mass/volume]",
        "value": 4.31,
        "unit": "g/dL",
        "date": "2025-07-03"
      }
    ],
    "family_history": [
      {
        "relationship": "Mother",
        "condition": "Lung cancer",
        "age_at_diagnosis": 58,
        "status": "Deceased",
        "year_of_death": 2018
      },
      {
        "relationship": "Father", 
        "condition": "Prostate cancer",
        "age_at_diagnosis": 65,
        "status": "Alive",
        "treatment": "Radical prostatectomy"
      },
      {
        "relationship": "Maternal aunt",
        "condition": "Breast cancer",
        "age_at_diagnosis": 52,
        "status": "Alive",
        "treatment": "Lumpectomy + chemotherapy"
      },
      {
        "relationship": "Paternal uncle",
        "condition": "Colon cancer",
        "age_at_diagnosis": 60,
        "status": "Deceased",
        "year_of_death": 2015
      }
    ],
    "genetics_counseling_and_consent": {
      "consent_id": "0687b566-e14f-4f73-be33-e44eff9ff0a3",
      "type": "Genetic testing consent",
      "date_signed": "2024-05-07",
      "elements_checked": [
        "purpose/scope",
        "genes/panel scope",
        "privacy/data use",
        "secondary findings",
        "re-contact policy"
      ],
      "signed_by": "Mia Johnson",
      "genetic_counselor": "Dr. Sarah Chen, MS, CGC",
      "counseling_date": "2024-05-07",
      "counseling_duration_minutes": 60,
      "risk_assessment_completed": true,
      "clinical_utility_discussed": true,
      "analytical_validity_discussed": true,
      "clinical_validity_discussed": true,
      "insurance_coverage_discussed": true,
      "alternative_testing_options_discussed": true,
      "limitations_discussed": true,
      "follow_up_plan_established": true
    },
    "pa_metadata": {
      "pa_id": "PA7350753",
      "status": "Submitted",
      "service_request": {
        "cpt": "81455",
        "icd10": "C34.90",
        "description": "Comprehensive Solid Tumor Panel (500 genes)",
        "units": 1,
        "dos": "2025-05-22",
        "place_of_service": "11 (Office)"
      },
      "payerspecific": {
        "ncd_90_2_applicable": true,
        "meets_criteria_flags": {
          "has_cancer_dx": true,
          "advanced_or_metastatic": true,
          "fda_approved_cdx_or_mac_coverage": true,
          "no_prior_comprehensive_ngs_same_tumor": false
        }
      },
      "attachments": [
        {
          "type": "Pathology report (CAP synoptic)",
          "doc_id": "DOC5803"
        },
        {
          "type": "Molecular report",
          "doc_id": "DOC6925"
        },
        {
          "type": "Oncology clinic note",
          "doc_id": "DOC4150"
        }
      ],
      "timestamps": {
        "submitted": "2025-06-30",
        "last_updated": "2025-01-18"
      }
    },
    "provenance": {
      "created_at": "2025-03-01",
      "author": "Mock EHR Seeder v1.0"
    },
    "clinical_notes": [
      {
        "note_id": "ee770dfc-8eff-4cd1-837c-198f88dc77a2",
        "type": "Progress Note (SOAP)",
        "author": "Dr. Jordan Rivera",
        "date": "2025-01-18",
        "text": "S: Mia Johnson seen in clinic for follow-up of Metastatic non-small cell lung cancer, adenocarcinoma, stage IV. Reports fatigue level 3/10, mild dyspnea on exertion. No fever, chest pain, or bleeding. \nO: ECOG 1. Vitals stable. Lungs clear. No focal neurologic deficits. Labs reviewed: Cr 1.2 mg/dL; Hgb 10.9 g/dL.\nA: Metastatic non-small cell lung cancer, adenocarcinoma, on active treatment. \n\nCOMPREHENSIVE GENOMIC PROFILING INDICATED:\n- Stage IV disease with metastatic spread\n- Adenocarcinoma histology\n- No prior comprehensive NGS testing\n- Strong family history of multiple cancers\n- Genetic counseling completed with Dr. Sarah Chen, MS, CGC\n- Informed consent obtained\n- Results will guide targeted therapy selection\n\nTEST ORDERED: Comprehensive Solid Tumor Panel (500 genes) (CPT 81455)\nPRIOR TESTS: 1 (limited hotspot panel only)\n\nMEDICAL NECESSITY DOCUMENTATION COMPLETE:\n✓ Genetic counseling documentation\n✓ Family history assessment\n✓ Clinical indication documented\n✓ Analytical and clinical validity discussed\n✓ Insurance coverage requirements met\n✓ Informed consent obtained\n\nP: Proceed with comprehensive genomic profiling. Prior authorization submitted with complete supporting documentation. Results will guide targeted therapy selection per NCCN guidelines."
      },
      {
        "note_id": "7dd678ae-f02e-4717-8479-bc7229d7ecd5",
        "type": "Oncology Consult",
        "author": "Dr. Jordan Rivera",
        "date": "2022-08-16",
        "text": "REASON FOR CONSULT: Metastatic non-small cell lung cancer, adenocarcinoma\n\nCLINICAL SUMMARY: Mia Johnson presents with metastatic non-small cell lung cancer, adenocarcinoma, AJCC stage IV (T2aN1M1a). Performance status ECOG 1. Patient has strong family history of multiple cancers including lung, prostate, breast, and colon cancer.\n\nMEDICAL NECESSITY FOR COMPREHENSIVE GENOMIC PROFILING:\n- Patient has advanced/metastatic cancer (Stage IV)\n- No prior comprehensive NGS testing on this tumor\n- Strong family history suggests potential hereditary component\n- Results will guide targeted therapy selection\n- TMB/MSI status needed for immunotherapy consideration\n- Patient meets NCCN guidelines for comprehensive genomic profiling\n\nCLINICAL INDICATION:\n- Stage IV non-small cell lung cancer\n- Adenocarcinoma histology\n- Metastatic disease present\n- Performance status suitable for treatment\n- No prior comprehensive genomic profiling\n- Family history of multiple cancers\n\nASSESSMENT/PLAN:\n1. Comprehensive tumor profiling (CPT 81455) - Comprehensive Solid Tumor Panel (500 genes)\n2. Genetic counseling completed with Dr. Sarah Chen, MS, CGC\n3. Informed consent obtained\n4. Results will guide targeted therapy selection\n5. Consider germline testing if suspicious variants identified\n\nMEDICAL NECESSITY JUSTIFICATION:\n- Results will directly impact treatment decisions\n- Patient eligible for targeted therapies based on molecular profile\n- TMB/MSI status critical for immunotherapy consideration\n- Family history warrants comprehensive assessment\n- Meets all insurance coverage criteria for advanced cancer\n\nPathology confirms histology consistent with diagnosis. All documentation requirements met for prior authorization."
      },
      {
        "note_id": "52443570-bbc2-464b-8c46-64391ef7e647",
        "type": "Pathology Report (Narrative)",
        "author": "Dept. of Pathology",
        "date": "2024-10-27",
        "text": "Specimen: Excisional biopsy from Lung, unspecified.\nMicroscopic Description: Invasive carcinoma with G3. Tumor measures 60 mm. Lymphovascular invasion: Present. Margins: Positive.\nLymph nodes examined: 6, positive: 4. Tumor cellularity estimated at 30%."
      },
      {
        "note_id": "fa751cc0-842e-4332-8dc9-54d8922ebecb",
        "type": "Molecular Report (Impression/Comment)",
        "author": "GenomeDx Clinical",
        "date": "2024-06-08",
        "text": "Comprehensive genomic profiling identified: EGFR c.2573T>G (p.L858R), TP53 c.743G>A (p.R248Q). \nSummary metrics: TMB 10 mut/Mb; MSI Stable; PD-L1 CPS 55.\nInterpretation: Detected alterations may confer sensitivity to FDA-labeled targeted therapies or clinical trials. See variant-level evidence annotations. Clinical correlation recommended."
      },
      {
        "note_id": "dc9c2a3c-e81f-49f5-a97f-71b46dfac8c8",
        "type": "Genetic Counseling Note",
        "author": "Dr. Sarah Chen, MS, CGC",
        "date": "2024-05-07",
        "text": "COMPREHENSIVE GENETIC COUNSELING SESSION - COMPLETED\n\nPATIENT: Mia Johnson (MRN: MRN542417)\nDIAGNOSIS: Metastatic non-small cell lung cancer, adenocarcinoma, Stage IV\nTEST REQUESTED: Comprehensive Solid Tumor Panel (500 genes) - CPT 81455\n\nFAMILY HISTORY ASSESSMENT:\n- Mother: Lung cancer diagnosed at age 58, deceased 2018\n- Father: Prostate cancer diagnosed at age 65, alive, treated with radical prostatectomy\n- Maternal aunt: Breast cancer diagnosed at age 52, alive, treated with lumpectomy + chemotherapy\n- Paternal uncle: Colon cancer diagnosed at age 60, deceased 2015\n\nRISK ASSESSMENT:\n- Strong family history of multiple cancer types suggests potential hereditary cancer syndrome\n- Patient's early-onset lung cancer (age 57) with family history warrants comprehensive genomic profiling\n- Clinical utility: Results may guide targeted therapy selection and identify germline risk factors\n\nCOUNSELING COMPONENTS COMPLETED:\n✓ Purpose and scope of testing explained\n✓ Genes/panel scope discussed (500 genes including actionable targets)\n✓ Privacy and data use policies reviewed\n✓ Secondary findings policy explained\n✓ Re-contact policy discussed\n✓ Clinical utility of results explained\n✓ Analytical validity discussed (99.9% sensitivity, 99.5% specificity)\n✓ Clinical validity discussed (FDA-approved companion diagnostics)\n✓ Insurance coverage and prior authorization process explained\n✓ Alternative testing options discussed\n✓ Limitations of testing explained\n✓ Follow-up plan established\n\nINFORMED CONSENT:\n- Patient demonstrates understanding of test purpose and limitations\n- Consent signed and witnessed\n- Copy provided to patient\n\nCLINICAL RECOMMENDATION:\n- Proceed with comprehensive genomic profiling\n- Results will be disclosed by ordering physician\n- Genetic counselor available for follow-up questions\n- Consider germline testing if suspicious variants identified\n\nDOCUMENTATION: Complete family history documented, risk assessment completed, informed consent obtained. All requirements for insurance coverage met."
      },
      {
        "note_id": "c1210055-0e56-45dd-87fd-1cdba307b48f",
        "type": "Utilization Management Communication",
        "author": "Prior Auth Coordinator",
        "date": "2025-06-30",
        "text": "PA PA7350753 submitted for Comprehensive Solid Tumor Panel (500 genes) (CPT 81455) to Medicare (Medicare Advantage HMO).\nIncluded attachments: pathology synoptic, molecular order, clinic note. Coverage rationale cites NCD 90.2 and plan policy; patient has advanced disease and no prior comprehensive NGS on same primary tumor = criteria met.\nAwaiting response; if pended, will upload additional evidence (progress note, imaging)."
      },
      {
        "note_id": "ceffcaf0-e88c-43f7-be27-45c7d9414d86",
        "type": "Radiology Report (Narrative)",
        "author": "Radiology Attending, MD",
        "date": "2024-12-10",
        "text": "CT CAP: Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe.\nImpression: Findings compatible with metastatic disease. Recommend correlation with clinical status and tumor kinetics."
      }
    ]
  },
  {
    "patient_admin": {
      "mrn": "MRN379946",
      "name": {
        "given": "Mia",
        "family": "Anderson"
      },
      "dob": "1967-08-21",
      "sex_at_birth": "Female",
      "gender_identity": "Female",
      "race": "Black or African American",
      "preferred_language": "Spanish",
      "address": "7415 Ash Ave, Hartford, CT",
      "contact": {
        "phone": "555-0155",
        "email": "mia.anderson@example.com"
      },
      "identifiers": {
        "payer_member_id": "1440801160",
        "group_id": "37552"
      }
    },
    "coverage": {
      "payer": "Medicare",
      "plan_type": "Medicare",
      "member_id": "1440801160",
      "group_id": "37552",
      "effective_start": "2024-04-18",
      "effective_end": null
    },
    "ordering_provider": {
      "name": "Dr. Jordan Rivera",
      "npi": "1993631208"
    },
    "rendering_facility": {
      "org_name": "Seaside Comprehensive Cancer Institute",
      "tin": "98-7654321",
      "npi": "1678901234",
      "location": "88 Coastal Rd, New Haven, CT",
      "phone": "203-555-0144"
    },
    "lab_performing": {
      "lab_name": "Precision Genomics Lab",
      "clia": "33D1234567",
      "npi": "1255388881"
    },
    "diagnosis_and_stage": {
      "primary_icd10": "C18.7",
      "description": "Metastatic colorectal cancer",
      "ajcc_edition": "8",
      "tnm": "T3N1M1",
      "stage_group": "IV",
      "ecog": 1,
      "date_of_diagnosis": "2024-07-09"
    },
    "pathology_synoptic": {
      "specimen": {
        "type": "Excisional biopsy",
        "site": "Colon, sigmoid",
        "collection_date": "2023-11-29",
        "fixation": "10% NBF",
        "tumor_purity_pct": 30
      },
      "histology": "Adenocarcinoma",
      "grade": "G2",
      "tumor_size_mm": 35,
      "margins": "Positive",
      "lvi": "Absent",
      "nodes_examined": 0,
      "nodes_positive": 1
    },
    "genomic_testing": {
      "current_test": {
        "test_id": "fa345ad1-bbb5-4e2d-8e2f-d626b25c62e8",
        "test_name": "Tumor/Normal Exome with RNA Fusion",
        "cpt": "81455",
        "loinc_report": "81247-9",
        "methodology": "DNA/RNA hybrid capture",
        "genes_analyzed": 372,
        "lab": {
          "lab_name": "Precision Genomics Lab",
          "clia": "33D1234567",
          "npi": "1255388881"
        },
        "specimen_link": {
          "type": "Excisional biopsy",
          "site": "Colon, sigmoid",
          "collection_date": "2023-11-29",
          "fixation": "10% NBF",
          "tumor_purity_pct": 30
        },
        "report_date": "2024-08-05",
        "results": {
          "variants": [
            {
              "gene": "BRAF",
              "hgvs": "c.1799T>A (p.V600E)",
              "tier": "I"
            },
            {
              "gene": "KRAS",
              "hgvs": "Wild-type",
              "tier": "NA"
            }
          ],
          "summary_metrics": {
            "MSI": "High",
            "TMB": 40,
            "PD-L1_cps": 5
          }
        },
        "classification_system": "AMP/ASCO/CAP tiers"
      },
      "prior_tests": []
    },
    "treatment_history": {
      "systemic_therapies": [
        {
          "rxnorm": "1597876",
          "drug": "Pembrolizumab",
          "start": "2024-06-12",
          "stop": null,
          "line_of_therapy": 1
        }
      ]
    },
    "imaging": [
      {
        "modality": "CT Chest/Abd/Pelvis",
        "date": "2025-02-09",
        "findings": "Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe",
        "accession": "ACC774079"
      }
    ],
    "labs": [
      {
        "loinc": "718-7",
        "name": "Hemoglobin [g/dL]",
        "value": 12.5,
        "unit": "g/dL",
        "date": "2024-09-28"
      },
      {
        "loinc": "777-3",
        "name": "Platelets [#/volume]",
        "value": 191,
        "unit": "10^3/uL",
        "date": "2024-09-09"
      },
      {
        "loinc": "2160-0",
        "name": "Creatinine [Mass/volume]",
        "value": 1.34,
        "unit": "mg/dL",
        "date": "2025-07-05"
      },
      {
        "loinc": "1751-7",
        "name": "Albumin [Mass/volume]",
        "value": 3.47,
        "unit": "g/dL",
        "date": "2025-03-14"
      }
    ],
    "family_history": [
      {
        "relationship": "Mother",
        "condition": "Breast cancer",
        "age_at_diagnosis": 52
      },
      {
        "relationship": "Maternal aunt",
        "condition": "Ovarian cancer",
        "age_at_diagnosis": 58
      }
    ],
    "genetics_counseling_and_consent": {
      "consent_id": "ca1bf7fa-7f06-4c01-987e-43274f78ffc4",
      "type": "Genetic testing consent",
      "date_signed": "2025-02-12",
      "elements_checked": [
        "purpose/scope",
        "genes/panel scope",
        "privacy/data use",
        "secondary findings",
        "re-contact policy"
      ],
      "signed_by": "Mia Anderson"
    },
    "pa_metadata": {
      "pa_id": "PA7073292",
      "status": "Pending clinical review",
      "service_request": {
        "cpt": "81455",
        "icd10": "C18.7",
        "description": "Tumor/Normal Exome with RNA Fusion",
        "units": 1,
        "dos": "2025-02-05",
        "place_of_service": "11 (Office)"
      },
      "payerspecific": {
        "ncd_90_2_applicable": true,
        "meets_criteria_flags": {
          "has_cancer_dx": true,
          "advanced_or_metastatic": true,
          "fda_approved_cdx_or_mac_coverage": true,
          "no_prior_comprehensive_ngs_same_tumor": true
        }
      },
      "attachments": [
        {
          "type": "Pathology report (CAP synoptic)",
          "doc_id": "DOC9348"
        },
        {
          "type": "Molecular report",
          "doc_id": "DOC9085"
        },
        {
          "type": "Oncology clinic note",
          "doc_id": "DOC2489"
        }
      ],
      "timestamps": {
        "submitted": "2025-07-13",
        "last_updated": "2025-01-13"
      }
    },
    "provenance": {
      "created_at": "2025-07-22",
      "author": "Mock EHR Seeder v1.0"
    },
    "clinical_notes": [
      {
        "note_id": "50c6e8ac-309d-4924-a772-ff5359062ce9",
        "type": "Progress Note (SOAP)",
        "author": "Dr. Jordan Rivera",
        "date": "2025-01-13",
        "text": "S: Mia Anderson seen in clinic for follow-up of Metastatic colorectal cancer, stage IV. Reports fatigue level 3/10, mild dyspnea on exertion. No fever, chest pain, or bleeding. \nO: ECOG 1. Vitals stable. Lungs clear. No focal neurologic deficits. Labs reviewed: Cr 1.34 mg/dL; Hgb 12.5 g/dL.\nA: Metastatic colorectal cancer, on active treatment. Molecular profiling ordered: Tumor/Normal Exome with RNA Fusion (CPT 81455). Noted prior tests count: 0.\nP: Proceed with molecular test. If actionable alterations present, will consider targeted therapy per guidelines. Will submit prior authorization today with supporting documents."
      },
      {
        "note_id": "0f7afa2b-650c-431b-9138-cb3a23d8b724",
        "type": "Oncology Consult",
        "author": "Dr. Jordan Rivera",
        "date": "2024-07-09",
        "text": "Reason for consult: Metastatic colorectal cancer. Summary: Mia Anderson presents with Metastatic colorectal cancer. AJCC stage IV. Performance status ECOG 1. Family history reviewed; genetic counseling offered.\nAssessment/Plan: Comprehensive tumor profiling to assess for targetable alterations and to estimate TMB/MSI. Consent obtained for genetic testing. Pathology confirms histology consistent with diagnosis."
      },
      {
        "note_id": "7e8ab43e-fed5-45ea-8294-d9e762b4efed",
        "type": "Pathology Report (Narrative)",
        "author": "Dept. of Pathology",
        "date": "2023-11-29",
        "text": "Specimen: Excisional biopsy from Colon, sigmoid.\nMicroscopic Description: Invasive carcinoma with G2. Tumor measures 35 mm. Lymphovascular invasion: Absent. Margins: Positive.\nLymph nodes examined: 0, positive: 1. Tumor cellularity estimated at 30%."
      },
      {
        "note_id": "d2ccd689-e73a-47c7-a86b-ef9ce26d8eed",
        "type": "Molecular Report (Impression/Comment)",
        "author": "Precision Genomics Lab",
        "date": "2024-08-05",
        "text": "Comprehensive genomic profiling identified: BRAF c.1799T>A (p.V600E), KRAS Wild-type. \nSummary metrics: TMB 40 mut/Mb; MSI High; PD-L1 CPS 5.\nInterpretation: Detected alterations may confer sensitivity to FDA-labeled targeted therapies or clinical trials. See variant-level evidence annotations. Clinical correlation recommended."
      },
      {
        "note_id": "74e8fc4e-7d2f-442c-88e2-e10ca926fbf5",
        "type": "Genetic Counseling Note",
        "author": "Genetic Counselor, MS, CGC",
        "date": "2025-02-12",
        "text": "Pre-test counseling conducted. Discussed benefits/limitations of tumor profiling and potential incidental/secondary findings. Consent elements reviewed: purpose/scope, genes/panel scope, privacy/data use, secondary findings, re-contact policy. Patient signed consent; copy filed.\nFamily history notable for: Mother - Breast cancer @ 52, Maternal aunt - Ovarian cancer @ 58.\nPlan: Disclose results with oncology; discuss implications for relatives if germline risk suspected."
      },
      {
        "note_id": "d3a5bca7-9e28-4e26-a9fb-dd98b6ab1869",
        "type": "Utilization Management Communication",
        "author": "Prior Auth Coordinator",
        "date": "2025-07-13",
        "text": "PA PA7073292 submitted for Tumor/Normal Exome with RNA Fusion (CPT 81455) to Medicare (Medicare Advantage HMO).\nIncluded attachments: pathology synoptic, molecular order, clinic note. Coverage rationale cites NCD 90.2 and plan policy; patient has advanced disease and no prior comprehensive NGS on same primary tumor = criteria met.\nAwaiting response; if pended, will upload additional evidence (progress note, imaging)."
      },
      {
        "note_id": "cc7600f3-13a3-4a46-822f-87524cac7007",
        "type": "Radiology Report (Narrative)",
        "author": "Radiology Attending, MD",
        "date": "2025-02-09",
        "text": "CT CAP: Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe.\nImpression: Findings compatible with metastatic disease. Recommend correlation with clinical status and tumor kinetics."
      }
    ]
  },
  {
    "patient_admin": {
      "mrn": "MRN813328",
      "name": {
        "given": "Evelyn",
        "family": "Hall"
      },
      "dob": "1954-07-13",
      "sex_at_birth": "Female",
      "gender_identity": "Female",
      "race": "Other",
      "preferred_language": "Spanish",
      "address": "3295 Ash Ave, Middletown, CT",
      "contact": {
        "phone": "555-0180",
        "email": "evelyn.hall@example.com"
      },
      "identifiers": {
        "payer_member_id": "3321691176",
        "group_id": "18484"
      }
    },
    "coverage": {
      "payer": "Cigna",
      "plan_type": "Commercial HMO",
      "member_id": "3321691176",
      "group_id": "18484",
      "effective_start": "2023-10-28",
      "effective_end": null
    },
    "ordering_provider": {
      "name": "Dr. Morgan Rivera",
      "npi": "1487182120"
    },
    "rendering_facility": {
      "org_name": "Seaside Comprehensive Cancer Institute",
      "tin": "98-7654321",
      "npi": "1678901234",
      "location": "88 Coastal Rd, New Haven, CT",
      "phone": "203-555-0144"
    },
    "lab_performing": {
      "lab_name": "OncoSeq Diagnostics",
      "clia": "22D0987654",
      "npi": "1437219993"
    },
    "diagnosis_and_stage": {
      "primary_icd10": "C50.912",
      "description": "HR+ / HER2- breast cancer",
      "ajcc_edition": "8",
      "tnm": "T2N1M0",
      "stage_group": "IIB",
      "ecog": 0,
      "date_of_diagnosis": "2022-06-27"
    },
    "pathology_synoptic": {
      "specimen": {
        "type": "Excisional biopsy",
        "site": "Breast, left",
        "collection_date": "2025-06-15",
        "fixation": "Alcohol-based",
        "tumor_purity_pct": 60
      },
      "histology": "Invasive ductal carcinoma",
      "grade": "G2",
      "tumor_size_mm": 60,
      "margins": "Negative",
      "lvi": "Not identified",
      "nodes_examined": 12,
      "nodes_positive": 1
    },
    "genomic_testing": {
      "current_test": {
        "test_id": "475d689f-9fab-460b-80e6-a782d22313ed",
        "test_name": "Solid Tumor Actionable 324",
        "cpt": "81455",
        "loinc_report": "81247-9",
        "methodology": "DNA targeted panel",
        "genes_analyzed": 432,
        "lab": {
          "lab_name": "OncoSeq Diagnostics",
          "clia": "22D0987654",
          "npi": "1437219993"
        },
        "specimen_link": {
          "type": "Excisional biopsy",
          "site": "Breast, left",
          "collection_date": "2025-06-15",
          "fixation": "Alcohol-based",
          "tumor_purity_pct": 60
        },
        "report_date": "2024-06-14",
        "results": {
          "variants": [
            {
              "gene": "PIK3CA",
              "hgvs": "c.3140A>G (p.H1047R)",
              "tier": "I"
            },
            {
              "gene": "ESR1",
              "hgvs": "c.1610A>G (p.Y537C)",
              "tier": "II"
            }
          ],
          "summary_metrics": {
            "ER": "Positive (90%)",
            "PR": "Positive (60%)",
            "HER2": "Negative",
            "MSI": "Stable",
            "TMB": 6
          }
        },
        "classification_system": "AMP/ASCO/CAP tiers"
      },
      "prior_tests": [
        {
          "test_name": "Hotspot panel 50",
          "date": "2024-03-08",
          "key_findings": [
            {
              "gene": "TP53",
              "hgvs": "p.R273C",
              "tier": "II"
            }
          ],
          "lab": {
            "lab_name": "Legacy Molecular",
            "clia": "12D0001111",
            "npi": "1555999999"
          }
        }
      ]
    },
    "treatment_history": {
      "systemic_therapies": []
    },
    "imaging": [
      {
        "modality": "CT Chest/Abd/Pelvis",
        "date": "2025-06-27",
        "findings": "Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe",
        "accession": "ACC100599"
      }
    ],
    "labs": [
      {
        "loinc": "718-7",
        "name": "Hemoglobin [g/dL]",
        "value": 13.1,
        "unit": "g/dL",
        "date": "2025-05-15"
      },
      {
        "loinc": "777-3",
        "name": "Platelets [#/volume]",
        "value": 129,
        "unit": "10^3/uL",
        "date": "2024-04-24"
      },
      {
        "loinc": "2160-0",
        "name": "Creatinine [Mass/volume]",
        "value": 1.53,
        "unit": "mg/dL",
        "date": "2024-11-10"
      },
      {
        "loinc": "1751-7",
        "name": "Albumin [Mass/volume]",
        "value": 3.43,
        "unit": "g/dL",
        "date": "2024-09-03"
      }
    ],
    "family_history": [
      {
        "relationship": "Mother",
        "condition": "Breast cancer",
        "age_at_diagnosis": 52
      },
      {
        "relationship": "Maternal aunt",
        "condition": "Ovarian cancer",
        "age_at_diagnosis": 58
      }
    ],
    "genetics_counseling_and_consent": {
      "consent_id": "e1253a00-a557-409e-838a-ff281b94243a",
      "type": "Genetic testing consent",
      "date_signed": "2024-03-21",
      "elements_checked": [
        "purpose/scope",
        "genes/panel scope",
        "privacy/data use",
        "secondary findings",
        "re-contact policy"
      ],
      "signed_by": "Evelyn Hall"
    },
    "pa_metadata": {
      "pa_id": "PA2437026",
      "status": "Denied - need additional documentation",
      "service_request": {
        "cpt": "81455",
        "icd10": "C50.912",
        "description": "Solid Tumor Actionable 324",
        "units": 1,
        "dos": "2025-07-28",
        "place_of_service": "11 (Office)"
      },
      "payerspecific": {
        "ncd_90_2_applicable": true,
        "meets_criteria_flags": {
          "has_cancer_dx": true,
          "advanced_or_metastatic": false,
          "fda_approved_cdx_or_mac_coverage": true,
          "no_prior_comprehensive_ngs_same_tumor": false
        }
      },
      "attachments": [
        {
          "type": "Pathology report (CAP synoptic)",
          "doc_id": "DOC2133"
        },
        {
          "type": "Molecular report",
          "doc_id": "DOC9727"
        },
        {
          "type": "Oncology clinic note",
          "doc_id": "DOC3060"
        }
      ],
      "timestamps": {
        "submitted": "2025-02-02",
        "last_updated": "2025-06-18"
      }
    },
    "provenance": {
      "created_at": "2025-05-16",
      "author": "Mock EHR Seeder v1.0"
    },
    "clinical_notes": [
      {
        "note_id": "d5d46dba-0615-4961-a0be-709c423a6071",
        "type": "Progress Note (SOAP)",
        "author": "Dr. Morgan Rivera",
        "date": "2025-06-18",
        "text": "S: Evelyn Hall seen in clinic for follow-up of HR+ / HER2- breast cancer, stage IIB. Reports fatigue level 3/10, mild dyspnea on exertion. No fever, chest pain, or bleeding. \nO: ECOG 0. Vitals stable. Lungs clear. No focal neurologic deficits. Labs reviewed: Cr 1.53 mg/dL; Hgb 13.1 g/dL.\nA: HR+ / HER2- breast cancer, on active treatment. Molecular profiling ordered: Solid Tumor Actionable 324 (CPT 81455). Noted prior tests count: 1.\nP: Proceed with molecular test. If actionable alterations present, will consider targeted therapy per guidelines. Will submit prior authorization today with supporting documents."
      },
      {
        "note_id": "e2e7a7c7-ff6f-44ca-a02b-d04aef9a5758",
        "type": "Oncology Consult",
        "author": "Dr. Morgan Rivera",
        "date": "2022-06-27",
        "text": "Reason for consult: HR+ / HER2- breast cancer. Summary: Evelyn Hall presents with HR+ / HER2- breast cancer. AJCC stage IIB. Performance status ECOG 0. Family history reviewed; genetic counseling offered.\nAssessment/Plan: Comprehensive tumor profiling to assess for targetable alterations and to estimate TMB/MSI. Consent obtained for genetic testing. Pathology confirms histology consistent with diagnosis."
      },
      {
        "note_id": "46e84d86-a55e-4da0-975c-ba4ac2ce0245",
        "type": "Pathology Report (Narrative)",
        "author": "Dept. of Pathology",
        "date": "2025-06-15",
        "text": "Specimen: Excisional biopsy from Breast, left.\nMicroscopic Description: Invasive carcinoma with G2. Tumor measures 60 mm. Lymphovascular invasion: Not identified. Margins: Negative.\nLymph nodes examined: 12, positive: 1. Tumor cellularity estimated at 60%."
      },
      {
        "note_id": "439d8370-d8a0-44ef-bc8b-71fd77914168",
        "type": "Molecular Report (Impression/Comment)",
        "author": "OncoSeq Diagnostics",
        "date": "2024-06-14",
        "text": "Comprehensive genomic profiling identified: PIK3CA c.3140A>G (p.H1047R), ESR1 c.1610A>G (p.Y537C). \nSummary metrics: TMB 6 mut/Mb; MSI Stable.\nInterpretation: Detected alterations may confer sensitivity to FDA-labeled targeted therapies or clinical trials. See variant-level evidence annotations. Clinical correlation recommended."
      },
      {
        "note_id": "6a3c5133-95b6-4d3b-b22b-050f93586f74",
        "type": "Genetic Counseling Note",
        "author": "Genetic Counselor, MS, CGC",
        "date": "2024-03-21",
        "text": "Pre-test counseling conducted. Discussed benefits/limitations of tumor profiling and potential incidental/secondary findings. Consent elements reviewed: purpose/scope, genes/panel scope, privacy/data use, secondary findings, re-contact policy. Patient signed consent; copy filed.\nFamily history notable for: Mother - Breast cancer @ 52, Maternal aunt - Ovarian cancer @ 58.\nPlan: Disclose results with oncology; discuss implications for relatives if germline risk suspected."
      },
      {
        "note_id": "bf4b2089-35ef-4a4f-bd2a-bd6b4d3c2234",
        "type": "Utilization Management Communication",
        "author": "Prior Auth Coordinator",
        "date": "2025-02-02",
        "text": "PA PA2437026 submitted for Solid Tumor Actionable 324 (CPT 81455) to Medicare (Medicare Advantage HMO).\nIncluded attachments: pathology synoptic, molecular order, clinic note. Coverage rationale cites NCD 90.2 and plan policy; patient has advanced disease and no prior comprehensive NGS on same primary tumor = criteria met.\nAwaiting response; if pended, will upload additional evidence (progress note, imaging)."
      },
      {
        "note_id": "c83b382f-b969-49c0-8dd7-f39ed7bc5190",
        "type": "Radiology Report (Narrative)",
        "author": "Radiology Attending, MD",
        "date": "2025-06-27",
        "text": "CT CAP: Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe.\nImpression: Findings compatible with metastatic disease. Recommend correlation with clinical status and tumor kinetics."
      }
    ]
  },
  {
    "patient_admin": {
      "mrn": "MRN559381",
      "name": {
        "given": "James",
        "family": "Thomas"
      },
      "dob": "1963-09-25",
      "sex_at_birth": "Male",
      "gender_identity": "Male",
      "race": "Asian",
      "preferred_language": "Spanish",
      "address": "7571 Chestnut St, Bristol, CT",
      "contact": {
        "phone": "555-0195",
        "email": "james.thomas@example.com"
      },
      "identifiers": {
        "payer_member_id": "3806077634",
        "group_id": "38845"
      }
    },
    "coverage": {
      "payer": "Husky Health CT",
      "plan_type": "HUSKY B",
      "member_id": "3806077634",
      "group_id": "38845",
      "effective_start": "2023-08-19",
      "effective_end": null
    },
    "ordering_provider": {
      "name": "Dr. Casey Chen",
      "npi": "1022585366"
    },
    "rendering_facility": {
      "org_name": "Riverbend Oncology Center",
      "tin": "12-3456789",
      "npi": "1987654321",
      "location": "123 Cancer Way, Ann Arbor, MI",
      "phone": "734-555-0110"
    },
    "lab_performing": {
      "lab_name": "Precision Genomics Lab",
      "clia": "33D1234567",
      "npi": "1255388881"
    },
    "diagnosis_and_stage": {
      "primary_icd10": "C43.59",
      "description": "Stage III melanoma",
      "ajcc_edition": "8",
      "tnm": "T3bN1M0",
      "stage_group": "IIIC",
      "ecog": 1,
      "date_of_diagnosis": "2022-05-25"
    },
    "pathology_synoptic": {
      "specimen": {
        "type": "Excisional biopsy",
        "site": "Skin of trunk",
        "collection_date": "2023-08-14",
        "fixation": "10% NBF",
        "tumor_purity_pct": 20
      },
      "histology": "Malignant melanoma",
      "grade": "Not applicable",
      "tumor_size_mm": 18,
      "margins": "Negative",
      "lvi": "Present",
      "nodes_examined": 0,
      "nodes_positive": 2
    },
    "genomic_testing": {
      "current_test": {
        "test_id": "ccf04f95-22b6-4abf-bb9e-57acee38a362",
        "test_name": "Melanoma Focused 100",
        "cpt": "81455",
        "loinc_report": "81247-9",
        "methodology": "DNA targeted panel",
        "genes_analyzed": 576,
        "lab": {
          "lab_name": "Precision Genomics Lab",
          "clia": "33D1234567",
          "npi": "1255388881"
        },
        "specimen_link": {
          "type": "Excisional biopsy",
          "site": "Skin of trunk",
          "collection_date": "2023-08-14",
          "fixation": "10% NBF",
          "tumor_purity_pct": 20
        },
        "report_date": "2024-08-31",
        "results": {
          "variants": [
            {
              "gene": "BRAF",
              "hgvs": "c.1799T>A (p.V600E)",
              "tier": "I"
            }
          ],
          "summary_metrics": {
            "MSI": "Stable",
            "TMB": 18,
            "PD-L1_cps": 1
          }
        },
        "classification_system": "AMP/ASCO/CAP tiers"
      },
      "prior_tests": [
        {
          "test_name": "Hotspot panel 50",
          "date": "2023-05-13",
          "key_findings": [
            {
              "gene": "TP53",
              "hgvs": "p.R273C",
              "tier": "II"
            }
          ],
          "lab": {
            "lab_name": "Legacy Molecular",
            "clia": "12D0001111",
            "npi": "1555999999"
          }
        }
      ]
    },
    "treatment_history": {
      "systemic_therapies": [
        {
          "rxnorm": "1597876",
          "drug": "Pembrolizumab",
          "start": "2024-07-15",
          "stop": null,
          "line_of_therapy": 1
        }
      ]
    },
    "imaging": [
      {
        "modality": "CT Chest/Abd/Pelvis",
        "date": "2024-08-07",
        "findings": "Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe",
        "accession": "ACC665427"
      }
    ],
    "labs": [
      {
        "loinc": "718-7",
        "name": "Hemoglobin [g/dL]",
        "value": 11.1,
        "unit": "g/dL",
        "date": "2025-04-29"
      },
      {
        "loinc": "777-3",
        "name": "Platelets [#/volume]",
        "value": 244,
        "unit": "10^3/uL",
        "date": "2025-04-29"
      },
      {
        "loinc": "2160-0",
        "name": "Creatinine [Mass/volume]",
        "value": 1.41,
        "unit": "mg/dL",
        "date": "2024-07-13"
      },
      {
        "loinc": "1751-7",
        "name": "Albumin [Mass/volume]",
        "value": 3.17,
        "unit": "g/dL",
        "date": "2025-03-17"
      }
    ],
    "family_history": [],
    "genetics_counseling_and_consent": {
      "consent_id": "ec653b29-23da-477b-b82a-f8186ad9517b",
      "type": "Genetic testing consent",
      "date_signed": "2024-12-28",
      "elements_checked": [
        "purpose/scope",
        "genes/panel scope",
        "privacy/data use",
        "secondary findings",
        "re-contact policy"
      ],
      "signed_by": "James Thomas"
    },
    "pa_metadata": {
      "pa_id": "PA8106470",
      "status": "Denied - need additional documentation",
      "service_request": {
        "cpt": "81455",
        "icd10": "C43.59",
        "description": "Melanoma Focused 100",
        "units": 1,
        "dos": "2025-04-30",
        "place_of_service": "11 (Office)"
      },
      "payerspecific": {
        "ncd_90_2_applicable": true,
        "meets_criteria_flags": {
          "has_cancer_dx": true,
          "advanced_or_metastatic": false,
          "fda_approved_cdx_or_mac_coverage": true,
          "no_prior_comprehensive_ngs_same_tumor": false
        }
      },
      "attachments": [
        {
          "type": "Pathology report (CAP synoptic)",
          "doc_id": "DOC1887"
        },
        {
          "type": "Molecular report",
          "doc_id": "DOC2612"
        },
        {
          "type": "Oncology clinic note",
          "doc_id": "DOC1993"
        }
      ],
      "timestamps": {
        "submitted": "2025-04-14",
        "last_updated": "2025-07-06"
      }
    },
    "provenance": {
      "created_at": "2025-02-18",
      "author": "Mock EHR Seeder v1.0"
    },
    "clinical_notes": [
      {
        "note_id": "11416701-b764-45c4-9a28-502fd3186e66",
        "type": "Progress Note (SOAP)",
        "author": "Dr. Casey Chen",
        "date": "2025-07-06",
        "text": "S: James Thomas seen in clinic for follow-up of Stage III melanoma, stage IIIC. Reports fatigue level 3/10, mild dyspnea on exertion. No fever, chest pain, or bleeding. \nO: ECOG 1. Vitals stable. Lungs clear. No focal neurologic deficits. Labs reviewed: Cr 1.41 mg/dL; Hgb 11.1 g/dL.\nA: Stage III melanoma, on active treatment. Molecular profiling ordered: Melanoma Focused 100 (CPT 81455). Noted prior tests count: 1.\nP: Proceed with molecular test. If actionable alterations present, will consider targeted therapy per guidelines. Will submit prior authorization today with supporting documents."
      },
      {
        "note_id": "3ceebe33-f7a3-4148-ae67-6776b42c48d4",
        "type": "Oncology Consult",
        "author": "Dr. Casey Chen",
        "date": "2022-05-25",
        "text": "Reason for consult: Stage III melanoma. Summary: James Thomas presents with Stage III melanoma. AJCC stage IIIC. Performance status ECOG 1. Family history reviewed; genetic counseling offered.\nAssessment/Plan: Comprehensive tumor profiling to assess for targetable alterations and to estimate TMB/MSI. Consent obtained for genetic testing. Pathology confirms histology consistent with diagnosis."
      },
      {
        "note_id": "47e721f9-abc2-4580-93ee-8f901bb998b1",
        "type": "Pathology Report (Narrative)",
        "author": "Dept. of Pathology",
        "date": "2023-08-14",
        "text": "Specimen: Excisional biopsy from Skin of trunk.\nMicroscopic Description: Invasive carcinoma with Not applicable. Tumor measures 18 mm. Lymphovascular invasion: Present. Margins: Negative.\nLymph nodes examined: 0, positive: 2. Tumor cellularity estimated at 20%."
      },
      {
        "note_id": "de200e52-a867-45b4-af25-7af087181360",
        "type": "Molecular Report (Impression/Comment)",
        "author": "Precision Genomics Lab",
        "date": "2024-08-31",
        "text": "Comprehensive genomic profiling identified: BRAF c.1799T>A (p.V600E). \nSummary metrics: TMB 18 mut/Mb; MSI Stable; PD-L1 CPS 1.\nInterpretation: Detected alterations may confer sensitivity to FDA-labeled targeted therapies or clinical trials. See variant-level evidence annotations. Clinical correlation recommended."
      },
      {
        "note_id": "9e8ce5bc-57f3-47c1-b806-27d3d9a3c15d",
        "type": "Genetic Counseling Note",
        "author": "Genetic Counselor, MS, CGC",
        "date": "2024-12-28",
        "text": "Pre-test counseling conducted. Discussed benefits/limitations of tumor profiling and potential incidental/secondary findings. Consent elements reviewed: purpose/scope, genes/panel scope, privacy/data use, secondary findings, re-contact policy. Patient signed consent; copy filed.\nFamily history notable for: non-contributory.\nPlan: Disclose results with oncology; discuss implications for relatives if germline risk suspected."
      },
      {
        "note_id": "72c47d9b-4eec-4eb3-82ff-95f1ab8944aa",
        "type": "Utilization Management Communication",
        "author": "Prior Auth Coordinator",
        "date": "2025-04-14",
        "text": "PA PA8106470 submitted for Melanoma Focused 100 (CPT 81455) to UnitedHealthcare (Commercial PPO).\nIncluded attachments: pathology synoptic, molecular order, clinic note. Coverage rationale cites NCD 90.2 and plan policy; patient has advanced disease and no prior comprehensive NGS on same primary tumor = criteria met.\nAwaiting response; if pended, will upload additional evidence (progress note, imaging)."
      },
      {
        "note_id": "39f28f58-a693-4f2c-946a-6a5426234d69",
        "type": "Radiology Report (Narrative)",
        "author": "Radiology Attending, MD",
        "date": "2024-08-07",
        "text": "CT CAP: Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe.\nImpression: Findings compatible with metastatic disease. Recommend correlation with clinical status and tumor kinetics."
      }
    ]
  },
  {
    "patient_admin": {
      "mrn": "MRN202664",
      "name": {
        "given": "Levi",
        "family": "Hernandez"
      },
      "dob": "1958-07-06",
      "sex_at_birth": "Female",
      "gender_identity": "Female",
      "race": "Hispanic/Latino",
      "preferred_language": "English",
      "address": "722 Hickory Rd, West Haven, CT",
      "contact": {
        "phone": "555-0119",
        "email": "levi.hernandez@example.com"
      },
      "identifiers": {
        "payer_member_id": "5807996872",
        "group_id": "15351"
      }
    },
    "coverage": {
      "payer": "Cigna",
      "plan_type": "Commercial PPO",
      "member_id": "5807996872",
      "group_id": "15351",
      "effective_start": "2024-05-12",
      "effective_end": null
    },
    "ordering_provider": {
      "name": "Dr. Riley Chen",
      "npi": "1928411292"
    },
    "rendering_facility": {
      "org_name": "Seaside Comprehensive Cancer Institute",
      "tin": "98-7654321",
      "npi": "1678901234",
      "location": "88 Coastal Rd, New Haven, CT",
      "phone": "203-555-0144"
    },
    "lab_performing": {
      "lab_name": "OncoSeq Diagnostics",
      "clia": "22D0987654",
      "npi": "1437219993"
    },
    "diagnosis_and_stage": {
      "primary_icd10": "C61",
      "description": "Metastatic castration-resistant prostate cancer",
      "ajcc_edition": "8",
      "tnm": "T3aN0M1b",
      "stage_group": "IVB",
      "ecog": 3,
      "date_of_diagnosis": "2024-06-22"
    },
    "pathology_synoptic": {
      "specimen": {
        "type": "Core needle biopsy",
        "site": "Prostate",
        "collection_date": "2023-06-18",
        "fixation": "Alcohol-based",
        "tumor_purity_pct": 20
      },
      "histology": "Adenocarcinoma",
      "grade": "G3",
      "tumor_size_mm": 35,
      "margins": "Positive",
      "lvi": "Absent",
      "nodes_examined": 20,
      "nodes_positive": 4
    },
    "genomic_testing": {
      "current_test": {
        "test_id": "52838d6c-833b-43fe-ae05-703bb09479dd",
        "test_name": "Prostate Comprehensive DNA/RNA",
        "cpt": "81455",
        "loinc_report": "81247-9",
        "methodology": "DNA targeted panel",
        "genes_analyzed": 244,
        "lab": {
          "lab_name": "OncoSeq Diagnostics",
          "clia": "22D0987654",
          "npi": "1437219993"
        },
        "specimen_link": {
          "type": "Core needle biopsy",
          "site": "Prostate",
          "collection_date": "2023-06-18",
          "fixation": "Alcohol-based",
          "tumor_purity_pct": 20
        },
        "report_date": "2024-10-30",
        "results": {
          "variants": [
            {
              "gene": "BRCA2",
              "hgvs": "c.5946del (p.S1982Rfs*22)",
              "tier": "I"
            },
            {
              "gene": "PTEN",
              "hgvs": "Deletion",
              "tier": "II"
            }
          ],
          "summary_metrics": {
            "MSI": "Stable",
            "TMB": 5,
            "PD-L1_cps": 0
          }
        },
        "classification_system": "AMP/ASCO/CAP tiers"
      },
      "prior_tests": [
        {
          "test_name": "Hotspot panel 50",
          "date": "2022-03-01",
          "key_findings": [
            {
              "gene": "TP53",
              "hgvs": "p.R273C",
              "tier": "II"
            }
          ],
          "lab": {
            "lab_name": "Legacy Molecular",
            "clia": "12D0001111",
            "npi": "1555999999"
          }
        }
      ]
    },
    "treatment_history": {
      "systemic_therapies": []
    },
    "imaging": [
      {
        "modality": "CT Chest/Abd/Pelvis",
        "date": "2025-07-09",
        "findings": "Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe",
        "accession": "ACC163918"
      }
    ],
    "labs": [
      {
        "loinc": "718-7",
        "name": "Hemoglobin [g/dL]",
        "value": 13.7,
        "unit": "g/dL",
        "date": "2024-02-28"
      },
      {
        "loinc": "777-3",
        "name": "Platelets [#/volume]",
        "value": 145,
        "unit": "10^3/uL",
        "date": "2025-05-03"
      },
      {
        "loinc": "2160-0",
        "name": "Creatinine [Mass/volume]",
        "value": 1.1,
        "unit": "mg/dL",
        "date": "2025-06-27"
      },
      {
        "loinc": "1751-7",
        "name": "Albumin [Mass/volume]",
        "value": 3.28,
        "unit": "g/dL",
        "date": "2025-06-04"
      }
    ],
    "family_history": [
      {
        "relationship": "Mother",
        "condition": "Breast cancer",
        "age_at_diagnosis": 52
      },
      {
        "relationship": "Maternal aunt",
        "condition": "Ovarian cancer",
        "age_at_diagnosis": 58
      }
    ],
    "genetics_counseling_and_consent": {
      "consent_id": "37442bee-4292-40dc-b772-5fa735b8900a",
      "type": "Genetic testing consent",
      "date_signed": "2024-03-23",
      "elements_checked": [
        "purpose/scope",
        "genes/panel scope",
        "privacy/data use",
        "secondary findings",
        "re-contact policy"
      ],
      "signed_by": "Levi Hernandez"
    },
    "pa_metadata": {
      "pa_id": "PA4117625",
      "status": "Submitted",
      "service_request": {
        "cpt": "81455",
        "icd10": "C61",
        "description": "Prostate Comprehensive DNA/RNA",
        "units": 1,
        "dos": "2025-06-02",
        "place_of_service": "11 (Office)"
      },
      "payerspecific": {
        "ncd_90_2_applicable": true,
        "meets_criteria_flags": {
          "has_cancer_dx": true,
          "advanced_or_metastatic": true,
          "fda_approved_cdx_or_mac_coverage": true,
          "no_prior_comprehensive_ngs_same_tumor": false
        }
      },
      "attachments": [
        {
          "type": "Pathology report (CAP synoptic)",
          "doc_id": "DOC2113"
        },
        {
          "type": "Molecular report",
          "doc_id": "DOC4853"
        },
        {
          "type": "Oncology clinic note",
          "doc_id": "DOC7615"
        }
      ],
      "timestamps": {
        "submitted": "2025-01-31",
        "last_updated": "2025-05-26"
      }
    },
    "provenance": {
      "created_at": "2025-01-21",
      "author": "Mock EHR Seeder v1.0"
    },
    "clinical_notes": [
      {
        "note_id": "128f0302-8ee7-4aa5-93d7-4f02d85c0b74",
        "type": "Progress Note (SOAP)",
        "author": "Dr. Riley Chen",
        "date": "2025-05-26",
        "text": "S: Levi Hernandez seen in clinic for follow-up of Metastatic castration-resistant prostate cancer, stage IVB. Reports fatigue level 3/10, mild dyspnea on exertion. No fever, chest pain, or bleeding. \nO: ECOG 3. Vitals stable. Lungs clear. No focal neurologic deficits. Labs reviewed: Cr 1.1 mg/dL; Hgb 13.7 g/dL.\nA: Metastatic castration-resistant prostate cancer, on active treatment. Molecular profiling ordered: Prostate Comprehensive DNA/RNA (CPT 81455). Noted prior tests count: 1.\nP: Proceed with molecular test. If actionable alterations present, will consider targeted therapy per guidelines. Will submit prior authorization today with supporting documents."
      },
      {
        "note_id": "1b391f34-7e9c-4442-bd8b-7eca4e011e50",
        "type": "Oncology Consult",
        "author": "Dr. Riley Chen",
        "date": "2024-06-22",
        "text": "Reason for consult: Metastatic castration-resistant prostate cancer. Summary: Levi Hernandez presents with Metastatic castration-resistant prostate cancer. AJCC stage IVB. Performance status ECOG 3. Family history reviewed; genetic counseling offered.\nAssessment/Plan: Comprehensive tumor profiling to assess for targetable alterations and to estimate TMB/MSI. Consent obtained for genetic testing. Pathology confirms histology consistent with diagnosis."
      },
      {
        "note_id": "87be3337-85b2-4447-b6bd-64fc9ed060ae",
        "type": "Pathology Report (Narrative)",
        "author": "Dept. of Pathology",
        "date": "2023-06-18",
        "text": "Specimen: Core needle biopsy from Prostate.\nMicroscopic Description: Invasive carcinoma with G3. Tumor measures 35 mm. Lymphovascular invasion: Absent. Margins: Positive.\nLymph nodes examined: 20, positive: 4. Tumor cellularity estimated at 20%."
      },
      {
        "note_id": "2e3bed10-4381-4617-9237-e94805d4a79e",
        "type": "Molecular Report (Impression/Comment)",
        "author": "OncoSeq Diagnostics",
        "date": "2024-10-30",
        "text": "Comprehensive genomic profiling identified: BRCA2 c.5946del (p.S1982Rfs*22), PTEN Deletion. \nSummary metrics: TMB 5 mut/Mb; MSI Stable; PD-L1 CPS 0.\nInterpretation: Detected alterations may confer sensitivity to FDA-labeled targeted therapies or clinical trials. See variant-level evidence annotations. Clinical correlation recommended."
      },
      {
        "note_id": "5e8868fa-b2ef-4fc8-a939-fcf0fb810455",
        "type": "Genetic Counseling Note",
        "author": "Genetic Counselor, MS, CGC",
        "date": "2024-03-23",
        "text": "Pre-test counseling conducted. Discussed benefits/limitations of tumor profiling and potential incidental/secondary findings. Consent elements reviewed: purpose/scope, genes/panel scope, privacy/data use, secondary findings, re-contact policy. Patient signed consent; copy filed.\nFamily history notable for: Mother - Breast cancer @ 52, Maternal aunt - Ovarian cancer @ 58.\nPlan: Disclose results with oncology; discuss implications for relatives if germline risk suspected."
      },
      {
        "note_id": "2b4bf1ec-aa0b-472f-a16a-9c1aa028f90b",
        "type": "Utilization Management Communication",
        "author": "Prior Auth Coordinator",
        "date": "2025-01-31",
        "text": "PA PA4117625 submitted for Prostate Comprehensive DNA/RNA (CPT 81455) to Medicare (Medicare Advantage HMO).\nIncluded attachments: pathology synoptic, molecular order, clinic note. Coverage rationale cites NCD 90.2 and plan policy; patient has advanced disease and no prior comprehensive NGS on same primary tumor = criteria met.\nAwaiting response; if pended, will upload additional evidence (progress note, imaging)."
      },
      {
        "note_id": "e331c024-287f-4a8d-8a13-1c632c192066",
        "type": "Radiology Report (Narrative)",
        "author": "Radiology Attending, MD",
        "date": "2025-07-09",
        "text": "CT CAP: Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe.\nImpression: Findings compatible with metastatic disease. Recommend correlation with clinical status and tumor kinetics."
      }
    ]
  },
  {
    "patient_admin": {
      "mrn": "MRN804318",
      "name": {
        "given": "Evelyn",
        "family": "Walker"
      },
      "dob": "1983-06-09",
      "sex_at_birth": "Male",
      "gender_identity": "Male",
      "race": "Asian",
      "preferred_language": "English",
      "address": "6694 Spruce Dr, New Haven, CT",
      "contact": {
        "phone": "555-0143",
        "email": "evelyn.walker@example.com"
      },
      "identifiers": {
        "payer_member_id": "5949553211",
        "group_id": "75379"
      }
    },
    "coverage": {
      "payer": "Humana",
      "plan_type": "Medicare Advantage PPO",
      "member_id": "5949553211",
      "group_id": "75379",
      "effective_start": "2023-01-10",
      "effective_end": null
    },
    "ordering_provider": {
      "name": "Dr. Casey Rivera",
      "npi": "1604509817"
    },
    "rendering_facility": {
      "org_name": "Seaside Comprehensive Cancer Institute",
      "tin": "98-7654321",
      "npi": "1678901234",
      "location": "88 Coastal Rd, New Haven, CT",
      "phone": "203-555-0144"
    },
    "lab_performing": {
      "lab_name": "GenomeDx Clinical",
      "clia": "06D2223334",
      "npi": "1992211110"
    },
    "diagnosis_and_stage": {
      "primary_icd10": "C56.9",
      "description": "Advanced ovarian cancer (HGSOC)",
      "ajcc_edition": "8",
      "tnm": "T3cN1M0",
      "stage_group": "IIIC",
      "ecog": 0,
      "date_of_diagnosis": "2024-07-22"
    },
    "pathology_synoptic": {
      "specimen": {
        "type": "Core needle biopsy",
        "site": "Ovary",
        "collection_date": "2024-07-04",
        "fixation": "10% NBF",
        "tumor_purity_pct": 60
      },
      "histology": "High-grade serous carcinoma",
      "grade": "G3",
      "tumor_size_mm": 22,
      "margins": "Positive",
      "lvi": "Present",
      "nodes_examined": 6,
      "nodes_positive": 2
    },
    "genomic_testing": {
      "current_test": {
        "test_id": "02dc637c-1675-4ded-865b-b711b4553899",
        "test_name": "BRCA1/2 Germline",
        "cpt": "81432",
        "loinc_report": "81247-9",
        "methodology": "WES + RNA",
        "genes_analyzed": 211,
        "lab": {
          "lab_name": "GenomeDx Clinical",
          "clia": "06D2223334",
          "npi": "1992211110"
        },
        "specimen_link": {
          "type": "Core needle biopsy",
          "site": "Ovary",
          "collection_date": "2024-07-04",
          "fixation": "10% NBF",
          "tumor_purity_pct": 60
        },
        "report_date": "2025-03-24",
        "results": {
          "variants": [
            {
              "gene": "BRCA1",
              "hgvs": "c.68_69delAG (p.Glu23Valfs*17)",
              "tier": "I"
            }
          ],
          "summary_metrics": {
            "MSI": "Stable",
            "TMB": 7
          }
        },
        "classification_system": "AMP/ASCO/CAP tiers"
      },
      "prior_tests": []
    },
    "treatment_history": {
      "systemic_therapies": []
    },
    "imaging": [
      {
        "modality": "CT Chest/Abd/Pelvis",
        "date": "2024-11-05",
        "findings": "Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe",
        "accession": "ACC741390"
      }
    ],
    "labs": [
      {
        "loinc": "718-7",
        "name": "Hemoglobin [g/dL]",
        "value": 14.7,
        "unit": "g/dL",
        "date": "2025-06-25"
      },
      {
        "loinc": "777-3",
        "name": "Platelets [#/volume]",
        "value": 124,
        "unit": "10^3/uL",
        "date": "2025-07-21"
      },
      {
        "loinc": "2160-0",
        "name": "Creatinine [Mass/volume]",
        "value": 0.9,
        "unit": "mg/dL",
        "date": "2024-04-16"
      },
      {
        "loinc": "1751-7",
        "name": "Albumin [Mass/volume]",
        "value": 4.69,
        "unit": "g/dL",
        "date": "2024-05-17"
      }
    ],
    "family_history": [
      {
        "relationship": "Mother",
        "condition": "Breast cancer",
        "age_at_diagnosis": 52
      },
      {
        "relationship": "Maternal aunt",
        "condition": "Ovarian cancer",
        "age_at_diagnosis": 58
      }
    ],
    "genetics_counseling_and_consent": {
      "consent_id": "ebb311e8-d437-4eb1-a312-177cc32a0564",
      "type": "Genetic testing consent",
      "date_signed": "2024-09-27",
      "elements_checked": [
        "purpose/scope",
        "genes/panel scope",
        "privacy/data use",
        "secondary findings",
        "re-contact policy"
      ],
      "signed_by": "Evelyn Walker"
    },
    "pa_metadata": {
      "pa_id": "PA2936571",
      "status": "Submitted",
      "service_request": {
        "cpt": "81432",
        "icd10": "C56.9",
        "description": "BRCA1/2 Germline",
        "units": 1,
        "dos": "2025-07-10",
        "place_of_service": "11 (Office)"
      },
      "payerspecific": {
        "ncd_90_2_applicable": true,
        "meets_criteria_flags": {
          "has_cancer_dx": true,
          "advanced_or_metastatic": false,
          "fda_approved_cdx_or_mac_coverage": true,
          "no_prior_comprehensive_ngs_same_tumor": true
        }
      },
      "attachments": [
        {
          "type": "Pathology report (CAP synoptic)",
          "doc_id": "DOC3546"
        },
        {
          "type": "Molecular report",
          "doc_id": "DOC5462"
        },
        {
          "type": "Oncology clinic note",
          "doc_id": "DOC5616"
        }
      ],
      "timestamps": {
        "submitted": "2025-06-04",
        "last_updated": "2025-02-23"
      }
    },
    "provenance": {
      "created_at": "2025-03-09",
      "author": "Mock EHR Seeder v1.0"
    },
    "clinical_notes": [
      {
        "note_id": "8955f6c7-015b-44be-9553-2df202ef76f2",
        "type": "Progress Note (SOAP)",
        "author": "Dr. Casey Rivera",
        "date": "2025-02-23",
        "text": "S: Evelyn Walker seen in clinic for follow-up of Advanced ovarian cancer (HGSOC), stage IIIC. Reports fatigue level 3/10, mild dyspnea on exertion. No fever, chest pain, or bleeding. \nO: ECOG 0. Vitals stable. Lungs clear. No focal neurologic deficits. Labs reviewed: Cr 0.9 mg/dL; Hgb 14.7 g/dL.\nA: Advanced ovarian cancer (HGSOC), on active treatment. Molecular profiling ordered: BRCA1/2 Germline (CPT 81432). Noted prior tests count: 0.\nP: Proceed with molecular test. If actionable alterations present, will consider targeted therapy per guidelines. Will submit prior authorization today with supporting documents."
      },
      {
        "note_id": "7cba827f-9fde-4c7e-9782-d008ce21f3d4",
        "type": "Oncology Consult",
        "author": "Dr. Casey Rivera",
        "date": "2024-07-22",
        "text": "Reason for consult: Advanced ovarian cancer (HGSOC). Summary: Evelyn Walker presents with Advanced ovarian cancer (HGSOC). AJCC stage IIIC. Performance status ECOG 0. Family history reviewed; genetic counseling offered.\nAssessment/Plan: Comprehensive tumor profiling to assess for targetable alterations and to estimate TMB/MSI. Consent obtained for genetic testing. Pathology confirms histology consistent with diagnosis."
      },
      {
        "note_id": "b3639ff3-a76e-4b11-ab30-cf7b82898c00",
        "type": "Pathology Report (Narrative)",
        "author": "Dept. of Pathology",
        "date": "2024-07-04",
        "text": "Specimen: Core needle biopsy from Ovary.\nMicroscopic Description: Invasive carcinoma with G3. Tumor measures 22 mm. Lymphovascular invasion: Present. Margins: Positive.\nLymph nodes examined: 6, positive: 2. Tumor cellularity estimated at 60%."
      },
      {
        "note_id": "b9f45f5d-182a-4067-9bbb-0b7704d36230",
        "type": "Molecular Report (Impression/Comment)",
        "author": "GenomeDx Clinical",
        "date": "2025-03-24",
        "text": "Comprehensive genomic profiling identified: BRCA1 c.68_69delAG (p.Glu23Valfs*17). \nSummary metrics: TMB 7 mut/Mb; MSI Stable.\nInterpretation: Detected alterations may confer sensitivity to FDA-labeled targeted therapies or clinical trials. See variant-level evidence annotations. Clinical correlation recommended."
      },
      {
        "note_id": "ed03650c-f9f4-4813-9fd5-56c74b2b7f46",
        "type": "Genetic Counseling Note",
        "author": "Genetic Counselor, MS, CGC",
        "date": "2024-09-27",
        "text": "Pre-test counseling conducted. Discussed benefits/limitations of tumor profiling and potential incidental/secondary findings. Consent elements reviewed: purpose/scope, genes/panel scope, privacy/data use, secondary findings, re-contact policy. Patient signed consent; copy filed.\nFamily history notable for: Mother - Breast cancer @ 52, Maternal aunt - Ovarian cancer @ 58.\nPlan: Disclose results with oncology; discuss implications for relatives if germline risk suspected."
      },
      {
        "note_id": "c5fb01b6-b188-483e-8107-e3dc8a2b34c7",
        "type": "Utilization Management Communication",
        "author": "Prior Auth Coordinator",
        "date": "2025-06-04",
        "text": "PA PA2936571 submitted for BRCA1/2 Germline (CPT 81432) to BlueShield CT (PPO).\nIncluded attachments: pathology synoptic, molecular order, clinic note. Coverage rationale cites NCD 90.2 and plan policy; patient has advanced disease and no prior comprehensive NGS on same primary tumor = criteria met.\nAwaiting response; if pended, will upload additional evidence (progress note, imaging)."
      },
      {
        "note_id": "b9fe0201-4479-4856-81ca-fe6b2997cec6",
        "type": "Radiology Report (Narrative)",
        "author": "Radiology Attending, MD",
        "date": "2024-11-05",
        "text": "CT CAP: Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe.\nImpression: Findings compatible with metastatic disease. Recommend correlation with clinical status and tumor kinetics."
      }
    ]
  },
  {
    "patient_admin": {
      "mrn": "MRN768061",
      "name": {
        "given": "Camila",
        "family": "Clark"
      },
      "dob": "1966-01-03",
      "sex_at_birth": "Female",
      "gender_identity": "Female",
      "race": "Asian",
      "preferred_language": "English",
      "address": "7355 Sycamore Ln, Bridgeport, CT",
      "contact": {
        "phone": "555-0110",
        "email": "camila.clark@example.com"
      },
      "identifiers": {
        "payer_member_id": "3190644685",
        "group_id": "75294"
      }
    },
    "coverage": {
      "payer": "Kaiser Permanente",
      "plan_type": "Medicare Advantage HMO",
      "member_id": "3190644685",
      "group_id": "75294",
      "effective_start": "2023-01-10",
      "effective_end": null
    },
    "ordering_provider": {
      "name": "Dr. Jordan Miller",
      "npi": "1948228268"
    },
    "rendering_facility": {
      "org_name": "Riverbend Oncology Center",
      "tin": "12-3456789",
      "npi": "1987654321",
      "location": "123 Cancer Way, Ann Arbor, MI",
      "phone": "734-555-0110"
    },
    "lab_performing": {
      "lab_name": "OncoSeq Diagnostics",
      "clia": "22D0987654",
      "npi": "1437219993"
    },
    "diagnosis_and_stage": {
      "primary_icd10": "C25.9",
      "description": "Metastatic pancreatic cancer",
      "ajcc_edition": "8",
      "tnm": "T4N1M1",
      "stage_group": "IV",
      "ecog": 1,
      "date_of_diagnosis": "2021-03-21"
    },
    "pathology_synoptic": {
      "specimen": {
        "type": "Excisional biopsy",
        "site": "Pancreas",
        "collection_date": "2023-02-06",
        "fixation": "Alcohol-based",
        "tumor_purity_pct": 60
      },
      "histology": "Ductal adenocarcinoma",
      "grade": "Not applicable",
      "tumor_size_mm": 22,
      "margins": "Positive",
      "lvi": "Present",
      "nodes_examined": 0,
      "nodes_positive": 2
    },
    "genomic_testing": {
      "current_test": {
        "test_id": "3096fdf8-a7fd-40dc-9f3a-b82f8e17e968",
        "test_name": "GI Solid Tumor 275",
        "cpt": "81455",
        "loinc_report": "81247-9",
        "methodology": "WES + RNA",
        "genes_analyzed": 90,
        "lab": {
          "lab_name": "OncoSeq Diagnostics",
          "clia": "22D0987654",
          "npi": "1437219993"
        },
        "specimen_link": {
          "type": "Excisional biopsy",
          "site": "Pancreas",
          "collection_date": "2023-02-06",
          "fixation": "Alcohol-based",
          "tumor_purity_pct": 60
        },
        "report_date": "2025-01-01",
        "results": {
          "variants": [
            {
              "gene": "KRAS",
              "hgvs": "c.35G>A (p.G12D)",
              "tier": "I"
            },
            {
              "gene": "CDKN2A",
              "hgvs": "Deletion",
              "tier": "II"
            }
          ],
          "summary_metrics": {
            "MSI": "Stable",
            "TMB": 3
          }
        },
        "classification_system": "AMP/ASCO/CAP tiers"
      },
      "prior_tests": [
        {
          "test_name": "Hotspot panel 50",
          "date": "2022-09-13",
          "key_findings": [
            {
              "gene": "TP53",
              "hgvs": "p.R273C",
              "tier": "II"
            }
          ],
          "lab": {
            "lab_name": "Legacy Molecular",
            "clia": "12D0001111",
            "npi": "1555999999"
          }
        }
      ]
    },
    "treatment_history": {
      "systemic_therapies": []
    },
    "imaging": [
      {
        "modality": "CT Chest/Abd/Pelvis",
        "date": "2024-04-15",
        "findings": "Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe",
        "accession": "ACC470858"
      }
    ],
    "labs": [
      {
        "loinc": "718-7",
        "name": "Hemoglobin [g/dL]",
        "value": 13.9,
        "unit": "g/dL",
        "date": "2025-02-20"
      },
      {
        "loinc": "777-3",
        "name": "Platelets [#/volume]",
        "value": 199,
        "unit": "10^3/uL",
        "date": "2024-08-30"
      },
      {
        "loinc": "2160-0",
        "name": "Creatinine [Mass/volume]",
        "value": 1.46,
        "unit": "mg/dL",
        "date": "2024-06-30"
      },
      {
        "loinc": "1751-7",
        "name": "Albumin [Mass/volume]",
        "value": 4.59,
        "unit": "g/dL",
        "date": "2024-01-26"
      }
    ],
    "family_history": [],
    "genetics_counseling_and_consent": {
      "consent_id": "e3a2bed0-1330-482e-bf95-6cd791f2fc8b",
      "type": "Genetic testing consent",
      "date_signed": "2024-07-02",
      "elements_checked": [
        "purpose/scope",
        "genes/panel scope",
        "privacy/data use",
        "secondary findings",
        "re-contact policy"
      ],
      "signed_by": "Camila Clark"
    },
    "pa_metadata": {
      "pa_id": "PA6573147",
      "status": "Denied - need additional documentation",
      "service_request": {
        "cpt": "81455",
        "icd10": "C25.9",
        "description": "GI Solid Tumor 275",
        "units": 1,
        "dos": "2025-07-25",
        "place_of_service": "11 (Office)"
      },
      "payerspecific": {
        "ncd_90_2_applicable": true,
        "meets_criteria_flags": {
          "has_cancer_dx": true,
          "advanced_or_metastatic": true,
          "fda_approved_cdx_or_mac_coverage": true,
          "no_prior_comprehensive_ngs_same_tumor": false
        }
      },
      "attachments": [
        {
          "type": "Pathology report (CAP synoptic)",
          "doc_id": "DOC5065"
        },
        {
          "type": "Molecular report",
          "doc_id": "DOC5371"
        },
        {
          "type": "Oncology clinic note",
          "doc_id": "DOC3608"
        }
      ],
      "timestamps": {
        "submitted": "2025-07-21",
        "last_updated": "2025-06-29"
      }
    },
    "provenance": {
      "created_at": "2025-05-01",
      "author": "Mock EHR Seeder v1.0"
    },
    "clinical_notes": [
      {
        "note_id": "529a8dd7-b147-4de7-bb71-672678c3bb38",
        "type": "Progress Note (SOAP)",
        "author": "Dr. Jordan Miller",
        "date": "2025-06-29",
        "text": "S: Camila Clark seen in clinic for follow-up of Metastatic pancreatic cancer, stage IV. Reports fatigue level 3/10, mild dyspnea on exertion. No fever, chest pain, or bleeding. \nO: ECOG 1. Vitals stable. Lungs clear. No focal neurologic deficits. Labs reviewed: Cr 1.46 mg/dL; Hgb 13.9 g/dL.\nA: Metastatic pancreatic cancer, on active treatment. Molecular profiling ordered: GI Solid Tumor 275 (CPT 81455). Noted prior tests count: 1.\nP: Proceed with molecular test. If actionable alterations present, will consider targeted therapy per guidelines. Will submit prior authorization today with supporting documents."
      },
      {
        "note_id": "b6a74cf2-ffe4-4631-88a3-dee0f17356ab",
        "type": "Oncology Consult",
        "author": "Dr. Jordan Miller",
        "date": "2021-03-21",
        "text": "Reason for consult: Metastatic pancreatic cancer. Summary: Camila Clark presents with Metastatic pancreatic cancer. AJCC stage IV. Performance status ECOG 1. Family history reviewed; genetic counseling offered.\nAssessment/Plan: Comprehensive tumor profiling to assess for targetable alterations and to estimate TMB/MSI. Consent obtained for genetic testing. Pathology confirms histology consistent with diagnosis."
      },
      {
        "note_id": "12b5b3a3-ca71-4bf4-87a1-08740ff4861a",
        "type": "Pathology Report (Narrative)",
        "author": "Dept. of Pathology",
        "date": "2023-02-06",
        "text": "Specimen: Excisional biopsy from Pancreas.\nMicroscopic Description: Invasive carcinoma with Not applicable. Tumor measures 22 mm. Lymphovascular invasion: Present. Margins: Positive.\nLymph nodes examined: 0, positive: 2. Tumor cellularity estimated at 60%."
      },
      {
        "note_id": "f4265840-045b-4f54-9b96-71811694e01d",
        "type": "Molecular Report (Impression/Comment)",
        "author": "OncoSeq Diagnostics",
        "date": "2025-01-01",
        "text": "Comprehensive genomic profiling identified: KRAS c.35G>A (p.G12D), CDKN2A Deletion. \nSummary metrics: TMB 3 mut/Mb; MSI Stable.\nInterpretation: Detected alterations may confer sensitivity to FDA-labeled targeted therapies or clinical trials. See variant-level evidence annotations. Clinical correlation recommended."
      },
      {
        "note_id": "69c6d09c-d68f-48d2-ae1e-3e43a1d775cd",
        "type": "Genetic Counseling Note",
        "author": "Genetic Counselor, MS, CGC",
        "date": "2024-07-02",
        "text": "Pre-test counseling conducted. Discussed benefits/limitations of tumor profiling and potential incidental/secondary findings. Consent elements reviewed: purpose/scope, genes/panel scope, privacy/data use, secondary findings, re-contact policy. Patient signed consent; copy filed.\nFamily history notable for: non-contributory.\nPlan: Disclose results with oncology; discuss implications for relatives if germline risk suspected."
      },
      {
        "note_id": "d564f0e0-0912-4e03-b44e-3093c0757059",
        "type": "Utilization Management Communication",
        "author": "Prior Auth Coordinator",
        "date": "2025-07-21",
        "text": "PA PA6573147 submitted for GI Solid Tumor 275 (CPT 81455) to BlueShield CT (PPO).\nIncluded attachments: pathology synoptic, molecular order, clinic note. Coverage rationale cites NCD 90.2 and plan policy; patient has advanced disease and no prior comprehensive NGS on same primary tumor = criteria met.\nAwaiting response; if pended, will upload additional evidence (progress note, imaging)."
      },
      {
        "note_id": "37dd6259-2d8b-4e7b-9e1b-d2f04f91b5e4",
        "type": "Radiology Report (Narrative)",
        "author": "Radiology Attending, MD",
        "date": "2024-04-15",
        "text": "CT CAP: Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe.\nImpression: Findings compatible with metastatic disease. Recommend correlation with clinical status and tumor kinetics."
      }
    ]
  },
  {
    "patient_admin": {
      "mrn": "MRN444207",
      "name": {
        "given": "Isabella",
        "family": "Smith"
      },
      "dob": "1979-06-10",
      "sex_at_birth": "Male",
      "gender_identity": "Male",
      "race": "Black or African American",
      "preferred_language": "English",
      "address": "4846 Hemlock Ln, Wallingford, CT",
      "contact": {
        "phone": "555-0194",
        "email": "isabella.smith@example.com"
      },
      "identifiers": {
        "payer_member_id": "1337838528",
        "group_id": "59691"
      }
    },
    "coverage": {
      "payer": "Husky Health CT",
      "plan_type": "HUSKY C",
      "member_id": "1337838528",
      "group_id": "59691",
      "effective_start": "2023-12-26",
      "effective_end": null
    },
    "ordering_provider": {
      "name": "Dr. Casey Miller",
      "npi": "1429151399"
    },
    "rendering_facility": {
      "org_name": "Midtown University Hospital",
      "tin": "11-2233445",
      "npi": "1223344556",
      "location": "10 University Ave, New York, NY",
      "phone": "212-555-0198"
    },
    "lab_performing": {
      "lab_name": "GenomeDx Clinical",
      "clia": "06D2223334",
      "npi": "1992211110"
    },
    "diagnosis_and_stage": {
      "primary_icd10": "C71.9",
      "description": "Glioblastoma, IDH-wildtype",
      "ajcc_edition": "8",
      "tnm": "NA",
      "stage_group": "IV (WHO grade 4)",
      "ecog": 2,
      "date_of_diagnosis": "2022-10-31"
    },
    "pathology_synoptic": {
      "specimen": {
        "type": "Core needle biopsy",
        "site": "Brain",
        "collection_date": "2023-04-29",
        "fixation": "Alcohol-based",
        "tumor_purity_pct": 30
      },
      "histology": "Glioblastoma, IDH-wildtype",
      "grade": "Not applicable",
      "tumor_size_mm": 35,
      "margins": "Negative",
      "lvi": "Present",
      "nodes_examined": 20,
      "nodes_positive": 2
    },
    "genomic_testing": {
      "current_test": {
        "test_id": "18a6ee27-9ea9-4cb1-8891-ac76ded75cb1",
        "test_name": "Neuro-Oncology Comprehensive",
        "cpt": "81455",
        "loinc_report": "81247-9",
        "methodology": "DNA/RNA hybrid capture",
        "genes_analyzed": 371,
        "lab": {
          "lab_name": "GenomeDx Clinical",
          "clia": "06D2223334",
          "npi": "1992211110"
        },
        "specimen_link": {
          "type": "Core needle biopsy",
          "site": "Brain",
          "collection_date": "2023-04-29",
          "fixation": "Alcohol-based",
          "tumor_purity_pct": 30
        },
        "report_date": "2025-03-22",
        "results": {
          "variants": [
            {
              "gene": "TERT",
              "hgvs": "Promoter mutation c.-124C>T",
              "tier": "II"
            },
            {
              "gene": "EGFR",
              "hgvs": "Amplification",
              "tier": "I"
            }
          ],
          "summary_metrics": {
            "MGMT": "Methylated",
            "TMB": 4
          }
        },
        "classification_system": "AMP/ASCO/CAP tiers"
      },
      "prior_tests": []
    },
    "treatment_history": {
      "systemic_therapies": []
    },
    "imaging": [
      {
        "modality": "CT Chest/Abd/Pelvis",
        "date": "2025-06-07",
        "findings": "Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe",
        "accession": "ACC221263"
      }
    ],
    "labs": [
      {
        "loinc": "718-7",
        "name": "Hemoglobin [g/dL]",
        "value": 12.2,
        "unit": "g/dL",
        "date": "2024-07-13"
      },
      {
        "loinc": "777-3",
        "name": "Platelets [#/volume]",
        "value": 250,
        "unit": "10^3/uL",
        "date": "2024-02-15"
      },
      {
        "loinc": "2160-0",
        "name": "Creatinine [Mass/volume]",
        "value": 1.31,
        "unit": "mg/dL",
        "date": "2024-01-02"
      },
      {
        "loinc": "1751-7",
        "name": "Albumin [Mass/volume]",
        "value": 3.94,
        "unit": "g/dL",
        "date": "2025-07-05"
      }
    ],
    "family_history": [],
    "genetics_counseling_and_consent": {
      "consent_id": "8db9a6a0-3e73-44d6-be0d-298ecd7d695b",
      "type": "Genetic testing consent",
      "date_signed": "2024-07-20",
      "elements_checked": [
        "purpose/scope",
        "genes/panel scope",
        "privacy/data use",
        "secondary findings",
        "re-contact policy"
      ],
      "signed_by": "Isabella Smith"
    },
    "pa_metadata": {
      "pa_id": "PA7110622",
      "status": "Denied - need additional documentation",
      "service_request": {
        "cpt": "81455",
        "icd10": "C71.9",
        "description": "Neuro-Oncology Comprehensive",
        "units": 1,
        "dos": "2025-01-18",
        "place_of_service": "11 (Office)"
      },
      "payerspecific": {
        "ncd_90_2_applicable": true,
        "meets_criteria_flags": {
          "has_cancer_dx": true,
          "advanced_or_metastatic": true,
          "fda_approved_cdx_or_mac_coverage": true,
          "no_prior_comprehensive_ngs_same_tumor": true
        }
      },
      "attachments": [
        {
          "type": "Pathology report (CAP synoptic)",
          "doc_id": "DOC6409"
        },
        {
          "type": "Molecular report",
          "doc_id": "DOC6143"
        },
        {
          "type": "Oncology clinic note",
          "doc_id": "DOC3041"
        }
      ],
      "timestamps": {
        "submitted": "2025-07-04",
        "last_updated": "2025-03-18"
      }
    },
    "provenance": {
      "created_at": "2025-04-14",
      "author": "Mock EHR Seeder v1.0"
    },
    "clinical_notes": [
      {
        "note_id": "b5269b38-5850-4e25-9359-cfb19bc21293",
        "type": "Progress Note (SOAP)",
        "author": "Dr. Casey Miller",
        "date": "2025-03-18",
        "text": "S: Isabella Smith seen in clinic for follow-up of Glioblastoma, IDH-wildtype, stage IV (WHO grade 4). Reports fatigue level 3/10, mild dyspnea on exertion. No fever, chest pain, or bleeding. \nO: ECOG 2. Vitals stable. Lungs clear. No focal neurologic deficits. Labs reviewed: Cr 1.31 mg/dL; Hgb 12.2 g/dL.\nA: Glioblastoma, IDH-wildtype, on active treatment. Molecular profiling ordered: Neuro-Oncology Comprehensive (CPT 81455). Noted prior tests count: 0.\nP: Proceed with molecular test. If actionable alterations present, will consider targeted therapy per guidelines. Will submit prior authorization today with supporting documents."
      },
      {
        "note_id": "1b322873-f602-4839-84a1-0b8da432d1f7",
        "type": "Oncology Consult",
        "author": "Dr. Casey Miller",
        "date": "2022-10-31",
        "text": "Reason for consult: Glioblastoma, IDH-wildtype. Summary: Isabella Smith presents with Glioblastoma, IDH-wildtype. AJCC stage IV (WHO grade 4). Performance status ECOG 2. Family history reviewed; genetic counseling offered.\nAssessment/Plan: Comprehensive tumor profiling to assess for targetable alterations and to estimate TMB/MSI. Consent obtained for genetic testing. Pathology confirms histology consistent with diagnosis."
      },
      {
        "note_id": "1f98087e-187b-4f73-a5f2-68aa1f2329ca",
        "type": "Pathology Report (Narrative)",
        "author": "Dept. of Pathology",
        "date": "2023-04-29",
        "text": "Specimen: Core needle biopsy from Brain.\nMicroscopic Description: Invasive carcinoma with Not applicable. Tumor measures 35 mm. Lymphovascular invasion: Present. Margins: Negative.\nLymph nodes examined: 20, positive: 2. Tumor cellularity estimated at 30%."
      },
      {
        "note_id": "74f7455c-44f1-4355-a7d8-750aaf5ee02b",
        "type": "Molecular Report (Impression/Comment)",
        "author": "GenomeDx Clinical",
        "date": "2025-03-22",
        "text": "Comprehensive genomic profiling identified: TERT Promoter mutation c.-124C>T, EGFR Amplification. \nSummary metrics: TMB 4 mut/Mb; MSI NA.\nInterpretation: Detected alterations may confer sensitivity to FDA-labeled targeted therapies or clinical trials. See variant-level evidence annotations. Clinical correlation recommended."
      },
      {
        "note_id": "a7754a35-fbb7-497c-a195-0fa59d90bd26",
        "type": "Genetic Counseling Note",
        "author": "Genetic Counselor, MS, CGC",
        "date": "2024-07-20",
        "text": "Pre-test counseling conducted. Discussed benefits/limitations of tumor profiling and potential incidental/secondary findings. Consent elements reviewed: purpose/scope, genes/panel scope, privacy/data use, secondary findings, re-contact policy. Patient signed consent; copy filed.\nFamily history notable for: non-contributory.\nPlan: Disclose results with oncology; discuss implications for relatives if germline risk suspected."
      },
      {
        "note_id": "820b709c-2c15-4efe-b2c7-d901a08cbb38",
        "type": "Utilization Management Communication",
        "author": "Prior Auth Coordinator",
        "date": "2025-07-04",
        "text": "PA PA7110622 submitted for Neuro-Oncology Comprehensive (CPT 81455) to BlueShield CT (PPO).\nIncluded attachments: pathology synoptic, molecular order, clinic note. Coverage rationale cites NCD 90.2 and plan policy; patient has advanced disease and no prior comprehensive NGS on same primary tumor = criteria met.\nAwaiting response; if pended, will upload additional evidence (progress note, imaging)."
      },
      {
        "note_id": "6812bed2-4fb8-4c7d-bd9f-3117082c3327",
        "type": "Radiology Report (Narrative)",
        "author": "Radiology Attending, MD",
        "date": "2025-06-07",
        "text": "CT CAP: Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe.\nImpression: Findings compatible with metastatic disease. Recommend correlation with clinical status and tumor kinetics."
      }
    ]
  },
  {
    "patient_admin": {
      "mrn": "MRN674553",
      "name": {
        "given": "Olivia",
        "family": "Young"
      },
      "dob": "1958-04-14",
      "sex_at_birth": "Female",
      "gender_identity": "Female",
      "race": "Black or African American",
      "preferred_language": "Japanese",
      "address": "7149 Cypress Way, New London, CT",
      "contact": {
        "phone": "555-0182",
        "email": "olivia.young@example.com"
      },
      "identifiers": {
        "payer_member_id": "6795397927",
        "group_id": "89573"
      }
    },
    "coverage": {
      "payer": "Kaiser Permanente",
      "plan_type": "Commercial HMO",
      "member_id": "6795397927",
      "group_id": "89573",
      "effective_start": "2024-03-16",
      "effective_end": null
    },
    "ordering_provider": {
      "name": "Dr. Jordan Chen",
      "npi": "1702984810"
    },
    "rendering_facility": {
      "org_name": "Midtown University Hospital",
      "tin": "11-2233445",
      "npi": "1223344556",
      "location": "10 University Ave, New York, NY",
      "phone": "212-555-0198"
    },
    "lab_performing": {
      "lab_name": "GenomeDx Clinical",
      "clia": "06D2223334",
      "npi": "1992211110"
    },
    "diagnosis_and_stage": {
      "primary_icd10": "C49.9",
      "description": "Metastatic soft-tissue sarcoma",
      "ajcc_edition": "8",
      "tnm": "T2N0M1",
      "stage_group": "IV",
      "ecog": 2,
      "date_of_diagnosis": "2023-05-21"
    },
    "pathology_synoptic": {
      "specimen": {
        "type": "Resection",
        "site": "Soft tissue",
        "collection_date": "2024-03-28",
        "fixation": "Alcohol-based",
        "tumor_purity_pct": 70
      },
      "histology": "Undifferentiated pleomorphic sarcoma",
      "grade": "G2",
      "tumor_size_mm": 60,
      "margins": "Positive",
      "lvi": "Not identified",
      "nodes_examined": 6,
      "nodes_positive": 0
    },
    "genomic_testing": {
      "current_test": {
        "test_id": "9af418b4-135f-47c7-b294-c24519a63345",
        "test_name": "Sarcoma Fusions & Mutations",
        "cpt": "81455",
        "loinc_report": "81247-9",
        "methodology": "WES + RNA",
        "genes_analyzed": 577,
        "lab": {
          "lab_name": "GenomeDx Clinical",
          "clia": "06D2223334",
          "npi": "1992211110"
        },
        "specimen_link": {
          "type": "Resection",
          "site": "Soft tissue",
          "collection_date": "2024-03-28",
          "fixation": "Alcohol-based",
          "tumor_purity_pct": 70
        },
        "report_date": "2024-12-09",
        "results": {
          "variants": [
            {
              "gene": "NTRK1",
              "hgvs": "ETV6-NTRK1 fusion",
              "tier": "I"
            }
          ],
          "summary_metrics": {
            "MSI": "Stable",
            "TMB": 8
          }
        },
        "classification_system": "AMP/ASCO/CAP tiers"
      },
      "prior_tests": [
        {
          "test_name": "Hotspot panel 50",
          "date": "2024-02-09",
          "key_findings": [
            {
              "gene": "TP53",
              "hgvs": "p.R273C",
              "tier": "II"
            }
          ],
          "lab": {
            "lab_name": "Legacy Molecular",
            "clia": "12D0001111",
            "npi": "1555999999"
          }
        }
      ]
    },
    "treatment_history": {
      "systemic_therapies": []
    },
    "imaging": [
      {
        "modality": "CT Chest/Abd/Pelvis",
        "date": "2024-08-28",
        "findings": "Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe",
        "accession": "ACC805477"
      }
    ],
    "labs": [
      {
        "loinc": "718-7",
        "name": "Hemoglobin [g/dL]",
        "value": 11.8,
        "unit": "g/dL",
        "date": "2024-07-22"
      },
      {
        "loinc": "777-3",
        "name": "Platelets [#/volume]",
        "value": 195,
        "unit": "10^3/uL",
        "date": "2024-01-26"
      },
      {
        "loinc": "2160-0",
        "name": "Creatinine [Mass/volume]",
        "value": 0.65,
        "unit": "mg/dL",
        "date": "2025-05-01"
      },
      {
        "loinc": "1751-7",
        "name": "Albumin [Mass/volume]",
        "value": 4.1,
        "unit": "g/dL",
        "date": "2024-03-15"
      }
    ],
    "family_history": [],
    "genetics_counseling_and_consent": {
      "consent_id": "710de395-00f9-497d-9676-2a807f3cf818",
      "type": "Genetic testing consent",
      "date_signed": "2025-04-11",
      "elements_checked": [
        "purpose/scope",
        "genes/panel scope",
        "privacy/data use",
        "secondary findings",
        "re-contact policy"
      ],
      "signed_by": "Olivia Young"
    },
    "pa_metadata": {
      "pa_id": "PA7953166",
      "status": "Pending clinical review",
      "service_request": {
        "cpt": "81455",
        "icd10": "C49.9",
        "description": "Sarcoma Fusions & Mutations",
        "units": 1,
        "dos": "2025-07-03",
        "place_of_service": "11 (Office)"
      },
      "payerspecific": {
        "ncd_90_2_applicable": true,
        "meets_criteria_flags": {
          "has_cancer_dx": true,
          "advanced_or_metastatic": true,
          "fda_approved_cdx_or_mac_coverage": true,
          "no_prior_comprehensive_ngs_same_tumor": false
        }
      },
      "attachments": [
        {
          "type": "Pathology report (CAP synoptic)",
          "doc_id": "DOC7291"
        },
        {
          "type": "Molecular report",
          "doc_id": "DOC9099"
        },
        {
          "type": "Oncology clinic note",
          "doc_id": "DOC7547"
        }
      ],
      "timestamps": {
        "submitted": "2025-03-04",
        "last_updated": "2025-02-07"
      }
    },
    "provenance": {
      "created_at": "2025-02-26",
      "author": "Mock EHR Seeder v1.0"
    },
    "clinical_notes": [
      {
        "note_id": "949ac9b7-0eff-409a-bc47-d634cf027e02",
        "type": "Progress Note (SOAP)",
        "author": "Dr. Jordan Chen",
        "date": "2025-02-07",
        "text": "S: Olivia Young seen in clinic for follow-up of Metastatic soft-tissue sarcoma, stage IV. Reports fatigue level 3/10, mild dyspnea on exertion. No fever, chest pain, or bleeding. \nO: ECOG 2. Vitals stable. Lungs clear. No focal neurologic deficits. Labs reviewed: Cr 0.65 mg/dL; Hgb 11.8 g/dL.\nA: Metastatic soft-tissue sarcoma, on active treatment. Molecular profiling ordered: Sarcoma Fusions & Mutations (CPT 81455). Noted prior tests count: 1.\nP: Proceed with molecular test. If actionable alterations present, will consider targeted therapy per guidelines. Will submit prior authorization today with supporting documents."
      },
      {
        "note_id": "47e18269-6cbe-4eb1-86c6-2574d0769486",
        "type": "Oncology Consult",
        "author": "Dr. Jordan Chen",
        "date": "2023-05-21",
        "text": "Reason for consult: Metastatic soft-tissue sarcoma. Summary: Olivia Young presents with Metastatic soft-tissue sarcoma. AJCC stage IV. Performance status ECOG 2. Family history reviewed; genetic counseling offered.\nAssessment/Plan: Comprehensive tumor profiling to assess for targetable alterations and to estimate TMB/MSI. Consent obtained for genetic testing. Pathology confirms histology consistent with diagnosis."
      },
      {
        "note_id": "4af0b54f-dfcb-4524-90fe-469a8fe0b496",
        "type": "Pathology Report (Narrative)",
        "author": "Dept. of Pathology",
        "date": "2024-03-28",
        "text": "Specimen: Resection from Soft tissue.\nMicroscopic Description: Invasive carcinoma with G2. Tumor measures 60 mm. Lymphovascular invasion: Not identified. Margins: Positive.\nLymph nodes examined: 6, positive: 0. Tumor cellularity estimated at 70%."
      },
      {
        "note_id": "31108f70-e746-4c29-be2c-4ed7b5ff3e5b",
        "type": "Molecular Report (Impression/Comment)",
        "author": "GenomeDx Clinical",
        "date": "2024-12-09",
        "text": "Comprehensive genomic profiling identified: NTRK1 ETV6-NTRK1 fusion. \nSummary metrics: TMB 8 mut/Mb; MSI Stable.\nInterpretation: Detected alterations may confer sensitivity to FDA-labeled targeted therapies or clinical trials. See variant-level evidence annotations. Clinical correlation recommended."
      },
      {
        "note_id": "c3996419-eab1-4037-b660-d0342da5b672",
        "type": "Genetic Counseling Note",
        "author": "Genetic Counselor, MS, CGC",
        "date": "2025-04-11",
        "text": "Pre-test counseling conducted. Discussed benefits/limitations of tumor profiling and potential incidental/secondary findings. Consent elements reviewed: purpose/scope, genes/panel scope, privacy/data use, secondary findings, re-contact policy. Patient signed consent; copy filed.\nFamily history notable for: non-contributory.\nPlan: Disclose results with oncology; discuss implications for relatives if germline risk suspected."
      },
      {
        "note_id": "09007321-f43c-4bdc-84e1-a3b2f56e41eb",
        "type": "Utilization Management Communication",
        "author": "Prior Auth Coordinator",
        "date": "2025-03-04",
        "text": "PA PA7953166 submitted for Sarcoma Fusions & Mutations (CPT 81455) to Medicare (Medicare Advantage HMO).\nIncluded attachments: pathology synoptic, molecular order, clinic note. Coverage rationale cites NCD 90.2 and plan policy; patient has advanced disease and no prior comprehensive NGS on same primary tumor = criteria met.\nAwaiting response; if pended, will upload additional evidence (progress note, imaging)."
      },
      {
        "note_id": "c4c932c7-602e-47ae-8d05-1542b9baa7da",
        "type": "Radiology Report (Narrative)",
        "author": "Radiology Attending, MD",
        "date": "2024-08-28",
        "text": "CT CAP: Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe.\nImpression: Findings compatible with metastatic disease. Recommend correlation with clinical status and tumor kinetics."
      }
    ]
  },
  {
    "patient_admin": {
      "mrn": "MRN800005",
      "name": {
        "given": "Sophia",
        "family": "Lewis"
      },
      "dob": "1979-01-18",
      "sex_at_birth": "Male",
      "gender_identity": "Male",
      "race": "White",
      "preferred_language": "Spanish",
      "address": "4165 Oak Ave, Danbury, CT",
      "contact": {
        "phone": "555-0127",
        "email": "sophia.lewis@example.com"
      },
      "identifiers": {
        "payer_member_id": "6515421029",
        "group_id": "33232"
      }
    },
    "coverage": {
      "payer": "UnitedHealthcare",
      "plan_type": "Commercial PPO",
      "member_id": "6515421029",
      "group_id": "33232",
      "effective_start": "2024-09-19",
      "effective_end": null
    },
    "ordering_provider": {
      "name": "Dr. Morgan Miller",
      "npi": "1458209399"
    },
    "rendering_facility": {
      "org_name": "Midtown University Hospital",
      "tin": "11-2233445",
      "npi": "1223344556",
      "location": "10 University Ave, New York, NY",
      "phone": "212-555-0198"
    },
    "lab_performing": {
      "lab_name": "GenomeDx Clinical",
      "clia": "06D2223334",
      "npi": "1992211110"
    },
    "diagnosis_and_stage": {
      "primary_icd10": "C92.00",
      "description": "Newly diagnosed AML",
      "ajcc_edition": "NA",
      "tnm": "NA",
      "stage_group": "NA",
      "ecog": 3,
      "date_of_diagnosis": "2024-04-11"
    },
    "pathology_synoptic": {
      "specimen": {
        "type": "Core needle biopsy",
        "site": "Bone marrow",
        "collection_date": "2025-01-31",
        "fixation": "Alcohol-based",
        "tumor_purity_pct": 50
      },
      "histology": "Acute myeloid leukemia",
      "grade": "G3",
      "tumor_size_mm": 22,
      "margins": "Not applicable",
      "lvi": "Absent",
      "nodes_examined": 20,
      "nodes_positive": 1
    },
    "genomic_testing": {
      "current_test": {
        "test_id": "443a7d75-368c-4417-8014-b8199efad84b",
        "test_name": "Heme Malignancy 54-gene",
        "cpt": "81450",
        "loinc_report": "81247-9",
        "methodology": "WES + RNA",
        "genes_analyzed": 500,
        "lab": {
          "lab_name": "GenomeDx Clinical",
          "clia": "06D2223334",
          "npi": "1992211110"
        },
        "specimen_link": {
          "type": "Core needle biopsy",
          "site": "Bone marrow",
          "collection_date": "2025-01-31",
          "fixation": "Alcohol-based",
          "tumor_purity_pct": 50
        },
        "report_date": "2024-03-20",
        "results": {
          "variants": [
            {
              "gene": "FLT3",
              "hgvs": "Internal tandem duplication",
              "tier": "I"
            },
            {
              "gene": "NPM1",
              "hgvs": "c.860_863dup (p.W288fs)",
              "tier": "I"
            }
          ],
          "summary_metrics": {
            "FLT3_ITD": "Positive",
            "NPM1": "Mutated"
          }
        },
        "classification_system": "AMP/ASCO/CAP tiers"
      },
      "prior_tests": []
    },
    "treatment_history": {
      "systemic_therapies": []
    },
    "imaging": [
      {
        "modality": "CT Chest/Abd/Pelvis",
        "date": "2024-08-28",
        "findings": "Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe",
        "accession": "ACC384913"
      }
    ],
    "labs": [
      {
        "loinc": "718-7",
        "name": "Hemoglobin [g/dL]",
        "value": 11.9,
        "unit": "g/dL",
        "date": "2025-07-07"
      },
      {
        "loinc": "777-3",
        "name": "Platelets [#/volume]",
        "value": 161,
        "unit": "10^3/uL",
        "date": "2024-05-21"
      },
      {
        "loinc": "2160-0",
        "name": "Creatinine [Mass/volume]",
        "value": 0.75,
        "unit": "mg/dL",
        "date": "2025-01-27"
      },
      {
        "loinc": "1751-7",
        "name": "Albumin [Mass/volume]",
        "value": 4.25,
        "unit": "g/dL",
        "date": "2024-08-07"
      }
    ],
    "family_history": [],
    "genetics_counseling_and_consent": {
      "consent_id": "a887adae-0ee2-46e1-8839-1880b381ec9e",
      "type": "Genetic testing consent",
      "date_signed": "2024-03-06",
      "elements_checked": [
        "purpose/scope",
        "genes/panel scope",
        "privacy/data use",
        "secondary findings",
        "re-contact policy"
      ],
      "signed_by": "Sophia Lewis"
    },
    "pa_metadata": {
      "pa_id": "PA7960328",
      "status": "Denied - need additional documentation",
      "service_request": {
        "cpt": "81450",
        "icd10": "C92.00",
        "description": "Heme Malignancy 54-gene",
        "units": 1,
        "dos": "2025-03-26",
        "place_of_service": "11 (Office)"
      },
      "payerspecific": {
        "ncd_90_2_applicable": true,
        "meets_criteria_flags": {
          "has_cancer_dx": true,
          "advanced_or_metastatic": false,
          "fda_approved_cdx_or_mac_coverage": true,
          "no_prior_comprehensive_ngs_same_tumor": true
        }
      },
      "attachments": [
        {
          "type": "Pathology report (CAP synoptic)",
          "doc_id": "DOC9890"
        },
        {
          "type": "Molecular report",
          "doc_id": "DOC8633"
        },
        {
          "type": "Oncology clinic note",
          "doc_id": "DOC7812"
        }
      ],
      "timestamps": {
        "submitted": "2025-01-16",
        "last_updated": "2025-02-22"
      }
    },
    "provenance": {
      "created_at": "2025-06-28",
      "author": "Mock EHR Seeder v1.0"
    },
    "clinical_notes": [
      {
        "note_id": "ee32671b-4c16-4ab2-993c-9dde8bef0d92",
        "type": "Progress Note (SOAP)",
        "author": "Dr. Morgan Miller",
        "date": "2025-02-22",
        "text": "S: Sophia Lewis seen in clinic for follow-up of Newly diagnosed AML, stage NA. Reports fatigue level 3/10, mild dyspnea on exertion. No fever, chest pain, or bleeding. \nO: ECOG 3. Vitals stable. Lungs clear. No focal neurologic deficits. Labs reviewed: Cr 0.75 mg/dL; Hgb 11.9 g/dL.\nA: Newly diagnosed AML, on active treatment. Molecular profiling ordered: Heme Malignancy 54-gene (CPT 81450). Noted prior tests count: 0.\nP: Proceed with molecular test. If actionable alterations present, will consider targeted therapy per guidelines. Will submit prior authorization today with supporting documents."
      },
      {
        "note_id": "12846c22-11da-4e1f-b08e-68d03db0829b",
        "type": "Oncology Consult",
        "author": "Dr. Morgan Miller",
        "date": "2024-04-11",
        "text": "Reason for consult: Newly diagnosed AML. Summary: Sophia Lewis presents with Newly diagnosed AML. AJCC stage NA. Performance status ECOG 3. Family history reviewed; genetic counseling offered.\nAssessment/Plan: Comprehensive tumor profiling to assess for targetable alterations and to estimate TMB/MSI. Consent obtained for genetic testing. Pathology confirms histology consistent with diagnosis."
      },
      {
        "note_id": "b1ae45f0-dd04-488b-8a55-735aa741dd3e",
        "type": "Pathology Report (Narrative)",
        "author": "Dept. of Pathology",
        "date": "2025-01-31",
        "text": "Specimen: Core needle biopsy from Bone marrow.\nMicroscopic Description: Invasive carcinoma with G3. Tumor measures 22 mm. Lymphovascular invasion: Absent. Margins: Not applicable.\nLymph nodes examined: 20, positive: 1. Tumor cellularity estimated at 50%."
      },
      {
        "note_id": "6218bd52-2afb-48d9-85d5-8e609b9b15cd",
        "type": "Molecular Report (Impression/Comment)",
        "author": "GenomeDx Clinical",
        "date": "2024-03-20",
        "text": "Comprehensive genomic profiling identified: FLT3 Internal tandem duplication, NPM1 c.860_863dup (p.W288fs). \nSummary metrics: TMB NA mut/Mb; MSI NA.\nInterpretation: Detected alterations may confer sensitivity to FDA-labeled targeted therapies or clinical trials. See variant-level evidence annotations. Clinical correlation recommended."
      },
      {
        "note_id": "72e43ef8-427a-4e4f-b24b-65cd42ffb329",
        "type": "Genetic Counseling Note",
        "author": "Genetic Counselor, MS, CGC",
        "date": "2024-03-06",
        "text": "Pre-test counseling conducted. Discussed benefits/limitations of tumor profiling and potential incidental/secondary findings. Consent elements reviewed: purpose/scope, genes/panel scope, privacy/data use, secondary findings, re-contact policy. Patient signed consent; copy filed.\nFamily history notable for: non-contributory.\nPlan: Disclose results with oncology; discuss implications for relatives if germline risk suspected."
      },
      {
        "note_id": "3bc5142a-46ec-4797-9134-523bf80daef4",
        "type": "Utilization Management Communication",
        "author": "Prior Auth Coordinator",
        "date": "2025-01-16",
        "text": "PA PA7960328 submitted for Heme Malignancy 54-gene (CPT 81450) to UnitedHealthcare (Commercial PPO).\nIncluded attachments: pathology synoptic, molecular order, clinic note. Coverage rationale cites NCD 90.2 and plan policy; patient has advanced disease and no prior comprehensive NGS on same primary tumor = criteria met.\nAwaiting response; if pended, will upload additional evidence (progress note, imaging)."
      },
      {
        "note_id": "dadb2415-ab8a-4139-938d-d18d44ba16ac",
        "type": "Radiology Report (Narrative)",
        "author": "Radiology Attending, MD",
        "date": "2024-08-28",
        "text": "CT CAP: Multiple bilateral pulmonary nodules; largest target lesion 28 mm right upper lobe.\nImpression: Findings compatible with metastatic disease. Recommend correlation with clinical status and tumor kinetics."
      }
    ]
  }
]